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ABSTRACT OF DISSERTATION

FACTORS INFLUENCING PREFERENCE FOR SURGICAL CHOICE AMONG
WOMEN WITH EARLY STAGE BREAST CANCER
Breast cancer is the most common cancer among women in the United States with
over 60% of cases diagnosed as early stage disease. For those women without prohibiting
clinical or cosmetic concerns, a choice between breast-conserving surgery and
mastectomy can be made. Either choice confers equivalent survival. The decision-making
process also involves consideration of recurrence risk as well as management of the
unaffected, contralateral breast for both future surveillance and risk reduction. In recent
years, increasing rates of mastectomy with contralateral prophylactic mastectomy have
been reported among women with unilateral, early stage breast cancer. If eligible for a
choice among surgical options, a woman’s decision becomes one of personal preference.
The decision-making process is complex and involves consideration of potential benefits
and harms with each option.
The purpose of this dissertation was to: 1) analyze the psychometric properties of
the Anxiety Subscale of the Depression Anxiety Stress Scale, 2) critically review
Decisional Conflict Scales and 3) prospectively identify demographic, clinical, cognitive
and affective factors influencing a woman’s decision to choose either breast conserving
surgery or mastectomy with contralateral prophylactic mastectomy and to identify selfreported sources of information in the surgical decision-making process.
Three manuscripts make up the dissertation. A secondary data analysis was
conducted to test the psychometric properties of the Anxiety Subscale of the Depression
Anxiety Stress Scale (DASS). The results of this analysis supported the reliability and
validity of the DASS anxiety subscale. A critical review of decisional conflict measures
for use with early stage breast cancer patients making surgical treatment decisions was
conducted. The results of this review supported the use of Decisional Conflict Scales
from a clinical and research perspective. Existing Decisional Conflict Scales show
moderate to acceptable reliability.
The first two manuscripts provided background and support for the use of scales
included in the research study described in the third manuscript. This study was a
prospective, exploratory, cross-sectional, mixed-methods study describing factors
influencing preference for surgical choice among women with early stage breast cancer.
A sample of 78 participants enrolled in the study, 47 who chose breast conserving
surgery and 31 who chose mastectomy with contralateral prophylactic mastectomy.

Differences were tested between the groups. Women who chose mastectomy with
contralateral prophylactic mastectomy were younger, more likely to work full or parttime, had larger tumors and participated in preoperative genetic counselling. Women who
chose breast conserving surgery were more likely to have participated in preoperative
breast magnetic resonance imaging. Overall, women choosing either surgery were not
experiencing severe levels of distress, depression, anxiety or stress although there were
individual variations. Women choosing mastectomy with contralateral prophylactic
mastectomy were more anxious and had more frequent intrusive thoughts about the
diagnosis. They also had less decisional conflict as compared to women choosing breast
conserving surgery. Information sources were similar but the most influential
information source differed among the two groups. In both groups, intention for surgical
choice was matched by the final decision. There are many factors influencing surgical
choice among women with early stage breast cancer. Previous work has focused on
clinical, demographic and diagnostic processes influencing the decision. With this study,
evidence regarding the influence of cognitive and affective factors is described.
KEYWORDS:
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Decisional conflict
Anxiety
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CHAPTER ONE:
Introduction
1.1. Breast Cancer and Surgical Treatment
Breast cancer continues to be the cancer of highest incidence among women in
the United States with 252,710 new cases projected in 2017 (Siegel, Miller, & Jemal,
2017). Declining mortality rates due to early detection and treatment advances have been
noted since the 1990’s yet breast cancer remains the second leading cause of cancerrelated death among women (DeSantis, Ma, Bryan, & Jemal, 2014). The majority of
breast cancer cases present as localized or early-stage disease, including non-invasive,
Stage 0 (in situ) and invasive, Stage I and II carcinomas. Early stage breast cancers
exhibit overall 5-year survival rates of 99% (Siegel et al., 2017).
For most women with unilateral early stage breast cancer, decision making among
surgical treatment options for the affected breast involves a choice between breastconserving surgery and mastectomy. With the addition of radiation therapy post-breast
conserving surgery, either choice confers equivalent survival according to stage of
disease (Early Breast Cancer Trialists' Group, 2011; Wong et al., 2017). Consideration is
also given to management of the unaffected, contralateral breast. In an average-risk
population (i.e. those without inherited genetic predisposition or history of breast
radiation exposure), risk of a contralateral breast cancer is low overall but increased as
compared to women with no history of breast cancer. The annual increased risk estimate
is in the range of 0.1-0.6% and 0.7-1.8% for women with ductal carcinoma in situ and
invasive carcinoma respectively (Boughey et al., 2016; Early Breast Cancer Trialists'
Group, 2011; Gao, Fisher, & Emami, 2003; Mamtani & Morrow, 2017; Quan, Pommier,
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& Pommier, 2008; Tuttle et al., 2009) Options for managing risk of a contralateral breast
cancer include a schedule of screening and early detection measures such as breast
imaging, chemoprevention with endocrine therapy agents, or contralateral prophylactic
mastectomy. In recent years, a significant trend in choosing contralateral prophylactic
mastectomy has been identified in women with ductal carcinoma in situ and invasive,
unilateral, early stage breast cancer (Jones et al., 2009; Pesce, Liederbach, Czechura,
Winchester, & Yao, 2014; Tuttle, Habermann, Grund, Morris, & Virnig, 2007; Tuttle et
al., 2009). The use of contralateral prophylactic mastectomy is an aggressive approach
from the perspective of the medical community, involving removal of a presumptively
normal organ for reduction of a seemingly low risk and without sufficient evidence of a
survival advantage.
1.2. Predictors of Surgical Choice
The breast cancer surgical decision-making process for a woman with early stage,
unilateral breast cancer is complex. The decision involves consideration of potential
benefits and harms with each option, as well as decisions about future surveillance and
risk. Options vary in regard to outcome, procedure, extent of surgery and recommended
follow-up. Decisions are preceded by recommendations from health care practitioners
from both disease and cosmetic perspective, opinions of family and significant others,
and personal choice including the influence of cognitive and affective factors. Ultimately,
the decision becomes one of personal preference in a decision-making process which is
poorly understood.
To date, most research into surgical decision making has been retrospective in
nature, using demographic and clinic information collected in large databases to evaluate
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predictors of surgical decision making. Factors such as age, ethnicity, and level of
education are examples of analysed variables as are clinical features such as tumor size
and receptor status. There is some evidence to suggest that distress, anxiety, uncertainty,
quality of life or worry about recurrence may be associated with surgical preference
(Goel, Sawka, Thiel, Gort, & O'Connor, 2001; Graves et al., 2007; Hawley et al., 2014;
Pedersen, Sawatzky, & Hack, 2010). There is a prevalent assumption in the more recent
medical literature suggesting women choosing mastectomy with CPM are not wellinformed about true local recurrence risk, contralateral breast cancer risk and survival
outcomes. Their surgical choice is described as an overestimation of risk and
misunderstanding about any survival advantage from that choice (Moffat & Yakoub,
2016). The medical community is called upon to develop research initiatives, decision
aids and supportive resources to assist women in this shared decision-making process
(Burke, Portschy, & Tuttle, 2015; Rosenberg et al., 2013).
1.3. Decision-Making
Regarding medical decision-making in general, a theory-practice gap has been
identified (Reyna, 2008). Decision aid and support interventions tested in practice are
not consistently based in identified theory, including many of the interventions which
have been the subject of randomized controlled trials (Durand, Stiel, Boivin, & Elwyn,
2008) . When applied, theoretical frameworks are often designed for normative decisionmaking and are primarily focused on the cognitive domain. The affective domain and
individual characteristics in decision-making are often absent in theoretical frameworks
in this subject area (Durand et al., 2008; Elwyn, Stiel, Durand, & Boivin, 2011; Pierce,
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1993). Research in the field is needed in order to inform the development of support and
counseling resources.
1.4. Summary of Subsequent Chapters
Chapter Two is a report on the psychometric properties of the Anxiety Subscale
of the Depression Anxiety Stress Scale in women undergoing a diagnostic mammogram.
It is a secondary analysis of existing data from a prospective study. Reliability and
validity of the Depression Anxiety Stress Scale anxiety subscale was tested in 2672
women who had been recalled for false-positive mammograms. Internal consistency
testing included Cronbach coefficient alpha and the split-half technique to determine
reliability. Construct validity was assessed and factor analysis was conducted. The
results of this analysis support the use of the DASS anxiety subscale as a reliable and
valid measure of anxiety among women undergoing a diagnostic mammogram.
Chapter Three is a critical review of decisional conflict measures. The purpose of
the analysis is to evaluate available decisional conflict scales for potential utilization at
the time of surgical decision making among women with early stage breast cancer.
Measurement of decisional conflict may promote the opportunity for high-quality
surgical decision making. Decisional conflict scales may also be utilized for research
with this population and in this setting. A review of the decisional conflict scale literature
was undertaken. Two scales were identified: the Decisional Conflict Scale and the Sure
of myself, Understand information, Risk-benefit ratio, Encouragement (SURE) screening
test. Psychometric properties of each scale were researched and summarized. The 16
item Decisional Conflict Scale is the standard, most widely accepted and tested
decisional conflict scale. The four item SURE scale is shorter and easier to use in a
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clinical setting. This analysis supported the use of decisional conflict scales with women
making surgical treatment decisions for breast cancer.
Chapter Four presents a prospective, exploratory, cross-sectional, mixed-methods
study examining factors influencing preference for surgical choice among women with
early stage breast cancer. Women were eligible to participate if they were newly
diagnosed with unilateral, early stage breast cancer (defined as Stage 0, I or II) and if they
were eligible to choose between the surgical options of breast conserving surgery or
mastectomy with or without contralateral prophylactic mastectomy. Analysis was limited
to those women who chose either breast conserving surgery or mastectomy with
contralateral prophylactic mastectomy; women choosing unilateral mastectomy were
excluded from analysis. A total of 78 women were included in this analysis, 47 in the
breast conserving surgery group and 31 in the bilateral mastectomy group. Differences in
demographic, diagnostic, clinical, cognitive and affective variables were tested between
the groups. Information sources were assessed by participant self-report. This study
demonstrated differences between the two groups. Women who chose mastectomy with
contralateral prophylactic mastectomy were younger, more likely to work full or parttime, had larger tumors, participated in preoperative genetic counselling, had higher
anxiety and breast cancer-specific distress. Women who chose breast conserving
surgery had higher decisional conflict. Information sources were similar between the two
groups but there were differences between the groups in the information source identified
as the most influential.
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CHAPTER TWO:
Psychometric Evaluation of the Anxiety Subscale of the Depression Anxiety Stress
Scale (DASS) in Women Recalled for False-Positive Mammograms
2.1. Background
Among women in the United States, breast cancer is the most common cancer and
the second leading cause of cancer-related mortality. Over 252,710 new cases of
invasive breast cancers and 40,610 deaths due to breast cancer were expected in 2017
(Siegel et al., 2017). Breast cancer screening using mammography has significantly
altered the diagnosis and prognosis of breast cancer, allowing for diagnosis in earlier
stages when cancers are small and may be non-invasive (American Cancer Society, 2013;
Smith, Duffy, & Tabar, 2012). The five year survival rate for these localized, early-stage
breast cancers is 99%, as compared to a five year survival rate of 85% for regional, and
26% for metastatic disease (Siegel et al., 2017) .
Cancer screening examinations including mammography are conducted on a
healthy population of at-risk individuals. As is the case with any screening activity,
potential benefits of screening a well population must be balanced against any potential
harms of the examination. Across all age groups, breast cancer screening with
mammography exhibits 86.9% sensitivity and 88.9% specificity. Sensitivity is highest
(88.5%) in older women with less dense breast tissue and lowest (73.4%) in women
between the ages of 40 and 44 (Breast Cancer Surveillance Consortium). An abnormal
screening exam results in follow-up or recall to a diagnostic phase consisting of
additional and focused mammography imaging which may include ultrasound, biopsy
and the use of other specific imaging technologies. In the United States, the average
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recall rate from screening mammography is 9.6%, ranging from 16.3% in women under
40 to 6.9% in women over 80. The majority of women recalled for diagnostic
mammograms will not have cancer, resulting in what is referred to as a false positive
recall (Breast Cancer Surveillance Consortium). One of the potential harms of false
positive recall is anxiety.
Heightened anxiety in women recalled for false positive mammograms has been
reported. The prevalence and severity of anxiety varies and is difficult to predict.
Research has been conducted using different measures and methods (Nelson et al., 2016).
In women with heightened anxiety, when contrasted with their baseline status or
compared to women who were not recalled from screening exams, short-term anxiety has
been found to be increased, with declining anxiety levels after negative results were
communicated (Brewer, Salz, & Lillie, 2007; Ekeberg, Skjauff, & Karesen, 2001; Nelson
et al., 2016; Schou Bredal, Karesen, Skaane, Engelstad, & Ekeberg, 2013). Long-term
anxiety may persist in some women for weeks, months and years after a false positive
mammogram (Bolejko, Hagell, Wann-Hansson, & Zackrisson, 2015; Brett & Austoker,
2001; Brodersen & Siersma, 2013; Gotzsche & Jorgensen, 2013; Hafslund, Espehaug, &
Nortvedt, 2012; Nelson et al., 2016). Recognition of subsets of women with elevated
anxiety in this population is recognized. Possible rationale may include the existence of
baseline or state anxiety as well as the combined effects of conditions such as depression,
decreased quality of life and diminished sense of well-being. Some women undergo more
imaging and procedures during this phase than others and anxiety levels may differ
accordingly. In addition, interventions on the part of healthcare providers such as
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communication, education, counselling and support may have an effect (Bolejko et al.,
2015; Nelson et al., 2016).
Measurement of anxiety in this population is inconsistent in method. Single
question items, visual analog/numeric rating scales and standardized anxiety scales and
subscales such as the State Trait Anxiety Inventory, Consequences of Screening in Breast
Cancer, Hospital Anxiety and Depression Scale, Impact of Events Scale, General Health
Questionnaire, and the Psychosocial Consequences Questionnaire have been used to
measure anxiety (Brett, Bankhead, Henderson, Watson, & Austoker, 2005; Brewer et al.,
2007; Montgomery & McCrone, 2010; Nelson et al., 2016; Watson, Henderson, Brett,
Bankhead, & Austoker, 2005). There is a wide variation in the timepoints at which
anxiety has been assessed including the time of recall and in the days, weeks, months and
years after a false-positive exam (Brett et al., 2005; Brewer et al., 2007; Brodersen &
Siersma, 2013; Gotzsche & Jorgensen, 2013; Nelson et al., 2016).
Despite evidence of anxiety among women recalled for false positive
mammograms, no consistent method or practice standard for measurement exists. A
scale that is reliable and valid, concise and implementable in practice for use in this
population could give caregivers a means to effectively diagnose anxiety. To date, use of
the DASS anxiety subscale in this population has not been reported. The purpose of this
study is to evaluate the psychometric properties of the DASS anxiety subscale in the
assessment of anxiety in women recalled for false positive mammograms. The specific
aims of this study were 1) to determine the reliability of the DASS anxiety subscale when
used with women recalled for false-positive mammograms and 2) to evaluate construct
and factorial validity of the DASS anxiety subscale. Internal consistency testing included
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Cronbach coefficient alpha and the split-half technique to determine reliability.
Construct validity was assessed using hypothesis testing. Factorial validity was examined
through factor analysis. The hypothesis tested was that of a negative correlation between
psychological well-being and anxiety (Winefield, Gill, Taylor, & Pikington, 2012).
2.2. Methods
2.2.1 Study design.
A secondary analysis of data from a descriptive, explanatory study examining the
psychological well-being of women undergoing diagnostic mammograms was conducted.
Subjects who were subsequently diagnosed with cancer were excluded from this analysis
in order to limit the sample to women recalled for a false-positive mammogram.
2.2.2 Samples and setting.
The original study was conducted in a breast imaging department of a 391-bed
Magnet®-designated hospital in the south eastern region of the United States. For all
participants in the study, data were collected during the diagnostic mammogram visit in
the healthcare setting and before results of the exam were known. Women were eligible
to participate if they were age 18 or older, able to read, write and understand English,
undergoing a diagnostic mammogram and if they provided consent to participate.
Women who had a prior personal history of cancer or were unable to complete the
questionnaires without assistance were excluded.
The convenience sample of women included 2973 total participants, 2928 of
whom were healthy and 45 of whom were subsequently diagnosed with breast cancer.
After removing those with breast cancer (n=45) and those with missing data, a total of
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2672 women recalled for a false positive mammogram remained and were included in
this analysis.
2.2.3 Procedure.
This study was approved by the study site’s Institutional Review Board. Potential
participants included all women undergoing diagnostic mammograms during the study
period. A research assistant introduced the study and invited women to participate as they
were waiting to be called for their diagnostic mammogram. Those who agreed to
participate, met criteria for inclusion and completed informed consent were enrolled in
the study. Women were provided a study packet of printed questionnaires to complete
and return before leaving the breast imaging department. Completion of the study packet
took approximately 20 minutes.
2.3. Variables and Measures
2.3.1 Demographics.
Demographic data were collected with a self-report questionnaire. Participants
were asked to report variables including age, race/ethnicity, marital status, level of
education, employment status, income level, primary wage earner status (yes/no),
religious affiliation and family history of cancer (yes/no/adopted).
2.3.2 Anxiety Subscale of the Depression Anxiety Stress Scale.
Anxiety was assessed using the Depression Anxiety Stress Scale (DASS). The
DASS consists of 42 items. Respondents are asked to identify and answer on a four-point
scale ranging from 0 (did not apply to me at all) to 3 (applied to me very much or most of
the time). Participants are asked to include experiences from the preceding week when
responding. Fourteen items of the DASS pertain to depression, 14 to anxiety and 14 to
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stress and items for each of these three subscales are interspersed among the other
subscale items. Higher scores represent higher depression, anxiety and stress on the
representative subscale.
Prior studies with the DASS have established good reliability and validity in both
clinical and non-clinical populations. Cronbach alpha in these studies for the overall
DASS have ranged from 0.84-0.897 (Crawford & Henry, 2003; Lovibond & Lovibond,
1995). Cronbach alpha for the DASS anxiety subscale likewise indicates good reliability,
ranging from 0.897- 0.92 (Antony, 1998; Brown, Chorpita, Korotitsch, & Barlow, 1997;
Crawford & Henry, 2003; Cunningham, Brown, Brooks, & Page, 2013; Nieuwenhuijsen,
de Boer, Verbeek, Blonk, & van Dijk, 2003). Validity of the DASS anxiety subscale has
been assessed using several methods. In a sample of over 700 psychology students,
concurrent validity was measured against the Beck Anxiety Inventory. The two scales
were highly correlated (r = 0.81) (Lovibond & Lovibond, 1995). Convergent validity
between the anxiety subscale of the DASS and the anxiety subscale of the Hospital
Anxiety and Depression Scale and the Personal Disturbance Scale, Beck Anxiety
Inventory and the State Trait Anxiety Inventory were significantly correlated across
studies with correlations ranging from r = 0.67 - 0.84. These findings indicate that the
DASS anxiety subscale conceptually measures anxiety similarly to other established
measures (Antony, 1998; Crawford & Henry, 2003; Nieuwenhuijsen et al., 2003).
Confirmatory factor analysis of the three subscales of the overall DASS has been
replicated with both community and clinical samples. No previous use of the DASS
anxiety subscale in women recalled for false-positive mammograms was found.
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2.3.3 Ryff Scale of Psychological Well-Being.
Psychological well-being was assessed using the Ryff Scale of Psychological
Well-Being (SPWB). Six dimensions of psychological well-being are measured with
separate subscales and include: autonomy, purpose in life, positive relations with others,
personal growth, environmental mastery, and self-acceptance. The total scale includes 84
items. Each subscale consists of 14 items to which participants are asked to rate
responses on a six-point Likert scale ranging from (1) strongly disagree to (6) strongly
agree. Higher scores indicate higher well-being. Internal consistency coefficients for the
subscales have tested between .86 and .93. Test retest of all subscales are in the range of
.81 - .88 (C. D. Ryff & Keyes, 1995; C.D. Ryff, 1989). The Ryff SPWB was used for
validity hypothesis testing in this analysis.
2.4. Methods for Testing Psychometric Properties of the DASS Anxiety Subscale
All data analysis was performed using IBM® SPSS® Statistics (version 21). The
level of significance was set at a p value of .05 or less. Descriptive statistics including
means, standard deviations and frequency percentages were used to characterize the
sample demographics.
2.4.1 Reliability.
Cronbach coefficient alpha, a measure of internal consistency among anxiety
subscale items, was used to determine reliability. A Cronbach coefficient alpha greater
than .70 was considered acceptable. Inter-item correlations and item-total correlations
were used to test the characteristics of the anxiety subscale items and to test their
relationship to each other. Inter-item correlations between .20 and .80 were considered
acceptable. Reliability was also tested using the split-half technique, which yields a
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Spearman-Brown coefficient greater than .70. A coefficient greater than 0.70 was
considered acceptable.
2.4.2 Construct and Factorial Validity.
Construct and factorial validity were assessed using hypothesis testing and factor
analysis. The hypothesis tested was that of a negative correlation between psychological
well-being and anxiety. To measure the strength of the hypothesized relationship
between anxiety and SPWB, scores were analyzed using the Pearson product-moment
correlation.
Confirmatory factor analysis of the DASS anxiety subscale was conducted.
Suitability for factor analysis was confirmed by evaluating the basic requirements of a
minimum number of at least three response options, minimum sample size (at least 100),
and ten cases per item. Bartlett’s test of sphericity was used to evaluate the correlation
matrix. Matrix sample adequacy was evaluated using the Keiser-Meyer-Olkin (KMO)
test. KMO criterion values greater than .60 were considered adequate. Principal
component analysis extraction with varimax rotation was performed; eigenvalues of
greater than one were retained and a scree test was used to plot the eigenvalues of the
factors. Loadings greater than .40 were used to identify items associated with a factor.
Crossloaded factors were defined as those loading similarly on more than one factor with
a difference of less than .20.
2.5. Results
2.5.1 Sample Characteristics.
Table 2.1 shows the characteristics of the women recalled for a false positive
mammogram (n = 2672). All demographic variables were self-reported and in some
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cases, were self-defined. For example the question asking about main wage earner status
asked “are you the main wage earner in your household?” and participants answered
“yes” or “no”. The sample was predominately Caucasian (92%), married/partnered
(71%), had completed college or graduate school (70%), was employed full- or part-time
(66%) and the majority reported an income level greater than $40,000 per year (72%).
Most participants did not identify themselves as the primary wage earner (62%). Over
90% identified themselves as having a religious affiliation and 69% had a family history
of cancer (< 1% were adopted or did not know). The mean age of women in this sample
was 50 (± 11).
The mean anxiety score was 4.3 (± 6, range 0-42) which is consistent with mean
normative DASS anxiety scores for women (Lovibond & Lovibond, 1995;
Nieuwenhuijsen et al., 2003). The median anxiety score was two. Anxiety scores ranged
from zero to forty-two. Six hundred fifteen women had an anxiety score of zero
accounting for 23% of the sample. Two women had a score of 42 (Table 2.2).
2.5.2 Reliability.
Cronbach alpha for the DASS anxiety subscale was .895, indicating good internal
consistency among the items. The overall mean for the anxiety subscale item correlations
in this sample was .396, indicating good interrelatedness among the items. Table 2.3
displays inter-item correlations, item-total correlations, means and standard deviations.
Inter-item correlations ranged from .217 - .633 indicating good correlations of each item
with the total score. Item specific means ranged from a low of .146 ± .447 to a high of
.634 ± .894. The standard deviation is higher than the mean for all items which is
indicative of the low overall anxiety scores in this sample.
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Deletion of any one item from the anxiety subscale would maintain the Cronbach
alpha between .88 - .90, therefore no indication of poor items in this subscale was found
(Table 2.4). The Spearman-Brown Coefficient for split-half reliability testing was
acceptable at .891
2.5.3 Construct Validity.
2.5.3.1 Hypothesis Testing.
To test the hypothesis of a negative correlation between DASS anxiety subscale
scores and SPWB scores, the Pearson product-moment correlation was calculated. A
significant negative correlation was found between anxiety and psychological well-being
(r = -.496, p < .01), resulting in a rejection of the null hypothesis.
2.5.3.2 Principal Component Analysis.
The 14 item DASS anxiety subscale was assessed with principal component
analysis (PCA). Before analysis, the suitability of the DASS anxiety subscale for PCA
was assessed. The subscale met the requirements for number of response criteria.
Requirements for sample size and number of cases per item were also met. Bartlett’s test
of sphericity was significant (p < .01) therefore the null hypothesis that the correlation
matrix is an identity matrix is rejected. The matrix sample adequacy is considered
adequate (KMO = .946) and the determination of the correlation matrix was adequate
(.004).
The minimum number of factors represented in the subscale was evaluated. Two
factors were retained and rotated using varimax rotation (Table 2.5) based on eigenvalues
greater than one, scree plot and explanation of total variance. The two factors split
between emotional/psychological manifestations of anxiety and physical manifestations
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of anxiety. Those items in the emotional/psychological dimension included words such
as panic, terror, feeling scared, fear and anxiety. Those items in the physical dimension
included DASS items referring to breathing difficulty, dry mouth, faintness, shakiness,
difficulty swallowing, heart rate or rhythm and perspiration. DASS item 41 “I found it
difficult to work up the initiative to do things” met criteria for retention and crossloading
(.509 for the first factor and .560 for the second factor). The item was retained to the
factor with the highest loading. A cutpoint of .40 was used to define factor loading.
2.6. Discussion
Reliability and validity of the DASS anxiety subscale in women undergoing false
positive recalls is supported by this analysis. Measures of internal consistency and
correlation of items within the subscale confirmed reliability in this sample. Construct
validity was supported with hypothesis testing. Factor analysis provided support for two
factors. The first factor includes six items which measure emotional/psychological
dimensions of anxiety such as panic, terror and fear. The second factor includes eight
items that measure action and physical symptoms of anxiety such as sweating, rapid or
irregular heart rate and dry mouth. One item met crossloading criteria (i.e. loading
similarly on more than one factor with a difference of less than .20) but fell more closely
within the second factor items in the physical dimension and was retained to that factor.
Although anxiety has been previously reported to be a negative effect of false
positive mammograms, the mean anxiety score of 4.3 for this sample falls within the
normal range. In this study, however, 23% of women had an anxiety score of zero. Five
percent reported anxiety levels over 15. Levels over 15 are considered high levels of
anxiety as measured by the DASS (Lovibond & Lovibond, 1995). This finding is
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consistent with previous reports in which a subset of women exhibit heightened anxiety
in this setting (Gotzsche & Jorgensen, 2013). It is possible that this subset of women
exhibited baseline heightened anxiety or trait anxiety. In this secondary analysis,
however, examination is limited to the data collected and examination of those
considerations is not possible. It is also possible that this sample is not representative of
the population. It was a convenience sample and subjects volunteered to be part of the
study. It is possible that the sample is biased toward women with lower anxiety who
volunteered to participate and absent those with heightened anxiety who refused to
participate.
In the original study, completion of the entire packet of questionnaires took less
than 20 minutes. The complete DASS was just one part of that packet. From a feasibility
perspective, use of the DASS anxiety subscale to assess anxiety would be possible in a
clinical setting. It would not take much time to complete and as demonstrated by the
original study, is easy to distribute as women wait for their diagnostic mammograms. The
subscale is concise, consisting of only 14 items. Currently, no consistent method or
practice standard for measurement of anxiety in this population of women exists but
implementation of an assessment tool could improve anxiety diagnosis, intervention and
overall quality of care in this setting.
2.7. Limitations
Secondary data analyses are limited to analyzing data on the variables that were
examined. For example, another measure of anxiety, even breast screening –specific
anxiety, may have provided meaningful information Variables were self-reported and
may be subject to bias. The sample was homogenous in terms of income, education and
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marital status. A sample drawn from a more heterogeneous population might have
produced different results. This positive skew may be reflective of the lack of volunteers
among women with heightened anxiety in this setting.
2.8. Conclusions
The DASS anxiety subscale showed good reliability in women recalled for false
positive mammograms and validity was supported by both hypothesis testing and factor
analysis. A 14-item subscale is concise and feasible for use in a clinical setting. The
potential benefits of breast cancer screening with mammography are evident in the
increased survival and shift toward early stage diagnosis. Potential harms, including
anxiety, still need to be addressed. Informed consent should ideally include accurate
information about potential benefits and harms of screening but until anxiety is
consistently measured and until the subsets of women with heightened anxiety are more
fully described, full disclosure of this potential harm is not possible. Consistent use of
the DASS anxiety subscale in this setting is encouraged as is the replication of reliability
and validity testing with its use in women recalled for false positive mammograms.
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Table 2.1
Characteristics of Women Recalled for False-Positive Mammograms
Total Sample
Demographic

(n = 2672)

Age (years), mean (± SD)

50 ± 11

Race/Ethnicity
Caucasian
Non-Caucasian

2459 (92)
213 (8)

Marital Status
Married/Partnered
Divorced/Separated/Single/
Widowed

1891 (71)
781 (29)

Education
Elementary/High School
College/Graduate School

800 (30)
1872 (70)

Employment
Full- or Part-Time
Other

1763 (66)
909 (34)

Income
<20,000
20,001 to 40,000
40,001 to 80, 000
>80,000

252 (9)
473 (18)
893 (33)
1054 (39)

Primary Wage Earner
Yes
No

1011 (38)
1661 (62)

Religious Affiliation
None
Catholic/Protestant/Jewish/Muslim/Other

251 (9)
2421 (91)

Family History of Cancer
Yes
No
Adopted

1833 (69)
820 (30)
19 (1)
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Table 2.2
DASS Anxiety Subscale Scores

Total Sample
(n = 2672)
Mean (± SD)

4.3 ± 6

Median

2

Range

0 – 42
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Table 2.3
DASS Anxiety Subscale Inter-item Correlations, Item-Total Correlations, Means and Standard Deviations
Item Correlations

DASS
2

DASS
4

DASS
7

DASS
9

DASS
15

DASS
19

DASS
20

DASS
23

DASS
25

DASS
28

DASS
30

DASS
36

DASS
40
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DASS
2

1.000

DASS
4

.306

1.000

DASS
7

.298

.457

1.000

DASS
9

.303

.379

.449

1.000

DASS
15

.276

.395

.501

.362

1.000

DASS
19

.259

.312

.384

.347

.327

1.000

DASS
20

.217

.346

.433

.424

.376

.367

1.000

DASS
23

.302

.393

.387

.332

.371

.265

.338

1.000

DASS
25

.265

.464

.413

.384

.390

.336

.400

.326

1.000

DASS
28

.286

.464

.504

.571

.456

.395

.591

.379

.478

1.000

DASS
30

.217

.323

.322

.457

.306

.289

.451

.306

.336

.483

1.000

DASS
36

.220

.349

.442

.424

.370

.334

.568

.319

.366

.633

.426

1.000

DASS
40

.267

.359

.440

.530

.341

.386

.493

.338

.386

.613

.536

.543

1.000

DASS
41

.313

.440

.610

.452

.468

.378

.439

.383

.433

.575

.385

.509

.520

DASS
41

1.000

Item-Total
Correlation

Mean

SD

.399

.634

.894

.574

.315

.680

.650

.270

.626

.629

.594

.827

.566

.146

.447

.501

.298

.685

.625

.256

.592

.508

.148

.462

.572

.384

.708

.752

.273

.656

.556

.279

.623

.633

.202

.572

.671

.282

.637

.685

.224

.599

DASS Subscale Items: DASS 2 “I was aware of dryness of my mouth,” DASS 4 “I experienced breathing difficulty (eg. excessively rapid breathing, breathlessness in the absence of physical exertion,” DASS 7 “I had a feeling of
shakiness (eg, legs going to give way,” DASS 9 “I found myself in situations that made me so anxious I was almost relieved when they ended,” DASS 15 “I had a feeling of faintness,” DASS 19 “I perspired noticeably (eg hands
sweaty) in the absence of high temperatures or physical exertion,” DASS 20 “I felt scared without any good reason,” DASS 23 “I had difficulty swallowing,” DASS 25 “I was aware of the action of my heart in the absence of
physical exertion (eg sense of heart rate increase, heart missing a beat),” DASS 28 I felt I was close to panic,” DASS 30 “I feared that I would be ‘thrown’ by some trivial but unfamiliar task,” DASS 36: “I fell terrified,” DASS40
“I was worried about situations in which I might panic and make a fool of myself,” DASS 41” I found it difficult to work up the initiative to do things”

Table 2.4
DASS Anxiety Subscale: Cronbach Alpha by Deleted Items
DASS Anxiety Subscale Item
DASS2
I was aware of dryness of my mouth
DASS4
I experienced breathing difficulty (eg excessively rapid breathing,
breathlessness in the absence of physical exertion)
DASS7
I had a feeling of shakiness (eg legs going to give way)
DASS9
I found myself in situations that made me so anxious I was almost relieved
when they ended
DASS15
I had a feeling of faintness
DASS19
I perspired noticeably (eg hands sweaty) in the absence of high temperatures
or physical exertion
DASS20
I felt scared without any good reason
DASS23
I had difficulty swallowing
DASS25
I was aware of the action of my heart in the absence of physical exertion (eg
sense of heart rate increase, heart missing a beat)
DASS28
I felt I was close to panic
DASS30
I feared that I would be “thrown” by some trivial but unfamiliar task
DASS36
I feel terrified
DASS40
I was worried about situations in which I might panic and make a fool of
myself
DASS41

I found it difficult to work up the initiative to do things
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Cronbach
alpha
if Item
Deleted
.900
.888

.885
.886

.890
.891

.886
.891
.888

.880
.889
.886
.884

.884

Table 2.5
Factor Analysis with Varimax Rotation of the DASS Anxiety Subscale (n = 2672)
Item

Factors

DASS 40
I was worried about situations in which I might panic and make a
fool of myself
DASS 36
I feel terrified
DASS 28
I felt I was close to panic
DASS 20
I felt scared without any good reason
DASS 30
I feared that I would be “thrown” by some trivial but unfamiliar
task
DASS 9
I found myself in situations that made me so anxious I was almost
relieved when they ended
DASS 4
I experienced breathing difficulty (eg excessively rapid breathing,
breathlessness in the absence of physical exertion)
DASS 2
I was aware of dryness of my mouth
DASS 15
I had a feeling of faintness
DASS 7
I had a feeling of shakiness (eg legs going to give way)
DASS 23
I had difficulty swallowing
DASS 41
I found it difficult to work up the initiative to do things
DASS 25
I was aware of the action of my heart in the absence of physical
exertion (eg sense of heart rate increase, heart missing a beat)
DASS 19
I perspired noticeably (eg hands sweaty) in the absence of high
temperatures or physical exertion
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.766

.247

.751

.227

.747

.385

.720

.245

.706

.151

.608

.362

.255

.675

.644
.282

.639

.395

.639

.215

.618

.509

.560

.364

.555

.380

.427

CHAPTER THREE:
Critical Review of Decisional Conflict Scales for Use during
Breast Cancer Surgical Decision Making
3.1. Introduction
Decisional conflict is defined as a perceived state of uncertainty about a course of
action (Legare et al., 2010; Annette M. O'Connor, 1995). It is more likely to occur when
making choices that are serious, affect potential gains and losses, involve risk, require
value trade-offs in the decision, and when regret, from either the choice taken or the
choice rejected, and is a possibility (Koedoot et al., 2001; A.M. O'Connor, 1993). The
surgery decision making process among women with early-stage breast cancer has the
potential for decisional conflict.
Decisional conflict is an indication of level of comfort with a decision (Annette M.
O'Connor, 1995). Among women with early-stage breast cancer, surgical decisions are
complex in and of themselves, but other factors may contribute to the complexity. The
time from diagnosis to surgical consultation is short, often spanning only a few days
resulting in a situation in which decisions are made quickly, possibly without sufficient
consideration. Consultation time with providers can be limited. In addition, health
literacy among women making these decisions may vary widely. Choices among
decisions may carry significant risk and hidden meaning. In this setting, measurement of
decisional conflict may facilitate communication between patients and healthcare
providers about the level of comfort with the surgical decision (Kokufu, 2012).
Opportunities for improvements in the decision making process may become apparent if
decisional conflict is known (Legare et al., 2003).
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Measurement of decisional conflict may also provide a method for evaluation of
interventions in this setting. For example, research on the effect of decision aids,
education or counseling sessions have included decisional conflict scales to evaluate the
effect of the intervention (Kryworuchko, Stacey, Bennett, & Graham, 2008; Obeidat,
Finnell, & Lally, 2011). The purpose of this critical review and analysis is to examine
decisional conflict measurement in order to evaluate utilization of those scales during the
time of surgical decision making among women with early-stage breast cancer from both
a research and clinical perspective.
3.2. Breast Cancer and Surgical Decisions
Breast cancer is the most commonly diagnosed cancer and the second leading cause
of cancer-related mortality among women in the United States. Over 252,710 new cases
of breast cancer and 40,610 deaths due to breast cancer are expected to occur in 2017
(Siegel et al., 2017). At time of presentation, the majority of breast cancers are unilateral
and localized. They are described as early-stage disease including Stage I, Stage II and
the non-invasive Stage 0 tumors (Siegel et al., 2017). For women with unilateral, earlystage breast cancer, surgical treatment options for the affected breast include either
breast-conserving surgery (BCS) or mastectomy. Some women choose mastectomy with
contralateral prophylactic mastectomy. Surgical choice in early-stage breast cancer is
described as a preference-based decision that is not well understood (Mamtani &
Morrow, 2017).
Choosing among surgical options is a shared decision making process involving
recommendations from health care providers from both a disease and cosmetic
perspective. Opinions of family and significant others as well as personal choice
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regarding the procedure are involved. Option-specific considerations of time, travel,
comfort and desired outcome may also be included. The potential for decisional conflict
is evident in this situation involving high-stakes choices which may impact risk of
recurrence and chance of survival. Potential loss or significant physical alterations of one
or both breasts, trade-offs in terms of quality of life and functioning due to treatment and
future surveillance, and potential future regret for any of the choices which are made are
also involved.
3.3. Decisional Conflict and Measurement
The identification of conflict as a component of decision making was described in the
1970’s in the conflict-theory model of decision making (Janis & Mann, 1976). In this
model, stress is recognized as a component of decision making, an influence on the
coping pattern exhibited throughout the decision making process and ultimately as an
alterant of the perceived quality of the decision. Stress from conflict may contribute to
failure in achieving high-quality decisions (Mann, Burnett, Radford, & Ford, 1997). High
quality decisions are thought to increase adherence and limit post decisional regret
(Balneaves & Long, 1999). More recent research into decision making reported decisions
as a review of a “personal balance account… [which] comprises the physical and
emotional gains patients hope to get minus the risks and other negative aspects.”(Noone,
2002) It is the choice between options that underlie conflict and stress. In the early
1990’s, O’Connor developed the Decisional Conflict Scale (DCS) to measure personal
perceptions of uncertainty in the decision, factors that add to perceptions of uncertainty
which are potentially modified (such as feeling unsupported in the decision) and the
effectiveness of the decision (A.M. O'Connor, 1993).
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Psychometric properties of the DCS were published in 1995 (Annette M. O'Connor,
1995). Subsequently, an adapted and shorter decisional conflict scale known as the Sure
of myself, Understand information, Risk-benefit ratio, Encouragement (SURE) screening
test was derived from the DCS (Legare et al., 2010). The DCS and SURE were chosen
for review and analysis. Characteristics of the scales are outlined in Table 3.1.
3.4. Analysis of Decisional Conflict Measures
3.4.1 Decisional Conflict Scale.
The original DCS consists of 16 total items in statement format. Responses are made
using a five point Likert scale ranging from 0 (strongly agree) to 4 (strongly disagree).
Total scores are summed, divided by 16 and then multiplied by 25, resulting in a
decisional conflict score ranging from 0 to 100. Low scores represent low decisional
conflict and high scores represent high decisional conflict. Scores above 37.5 are
associated with feeling unsure about the decision and with decisional delay (Annette M.
O'Connor, 1995). The DCS is formatted at an 8th grade reading level and takes 10 – 20
minutes to complete (Legare et al., 2010; A.M. O'Connor, 1993; Annette M. O'Connor,
1995).
The 16-item DCS is made up of the following five subscales: uncertainty, informed,
values clarity, support, and effective decision. Three items constitute each subscale
except for the effective decision subscale which includes four items. The effective
decision subscale is intended for use only after a decision has been made. Other subscales
may be used in the process of decision making and/or after a decision has been made.
High subscale scores represent high decisional conflict in that specific area. No specific
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score is identified as indicative of high verses low decisional conflict within a subscale
(A.M. O'Connor, 1993).
A summary of DCS and subscale reliability and validity is provided in Table 3.2.
Various formats, translations and modifications of formats have been tested and reported.
Coefficient alpha for the total DCS has been acceptable (α > 0.70 in all reports)
(Katapodi, Munro, Pierce, & Williams, 2011; Linder et al., 2011; Mancini, Santin,
Chabal, & Julian-Reynier, 2006; A.M. O'Connor, 1993; Annette M. O'Connor, 1995).
Psychometric testing of DCS English and French versions, when the scale was postexploratory, reported coefficient alphas > 0.90 which may suggest item redundancy. In
both reports, factor analysis resulted in an alternate factor model (Katapodi et al., 2011;
Mancini et al., 2006). Lam, et al. (2012), tested a Chinese version of the DCS and found
two cross-loading items, one from the uncertainty subscale “Are you clear about the best
choice for you?” and one from the effective decision subscale, ‘Do you feel you have
made an informed choice?” Both were removed. The coefficient alpha tested on the 14item scale = 0.81.
Subscale reliability testing is difficult to summarize owing to the modifications made
to subscales across reports (see Table 3.2). The original three subscales are reported by
O’Connor (1995) and Koedoot (2001). Modified subscales are reported by Katapodi
(2011) and Lam (2012). The current five subscales for the 16-item DCS are reported by
Mancini (2006). Linder (2011) tested the 10-item DCS and reported the standard four
subscales of informed, values clarity, support and uncertainty (Linder et al., 2011). The
support subscale resulted in coefficient alpha <0.70 in three reports, two of which tested
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the standard DCS subscales (Linder et al., 2011; Mancini et al., 2006) and one which
tested a modified support subscale (Lam et al., 2012).
Tests of validity have included the known-groups approach in which groups within
samples were compared based on whether a decision had been made or not. Hypotheses
testing was also reported (Table 3.2). In each test of validity, the DCS performed well.
Factor analysis has been conducted without confirmation of the current scale’s five-factor
model. Mancini (2006) and Koedoot (2001) report a four-factor model, Katapodi (2011)
and Lam (2012) report a three-factor model. Regarding the low-literacy, 10-item version
of the DCS, a four-factor model was confirmed (Linder et al., 2011).
The groups chosen for reliability and validity testing were dissimilar as was the
gravity of the decision being made. The samples included healthy populations of students
and healthcare workers considering influenza vaccination and healthy women
considering breast cancer screening as well as women newly diagnosed with breast
cancer considering treatment and those with metastatic cancer considering palliative
chemotherapy. Context of decision-making may warrant consideration in evaluating DCS
and subscales psychometrics as noted by Mancini (2006) with low level of conflict
making it more difficult to distinguish between factors when tested (Mancini et al., 2006).
English, French, Dutch and Chinese versions of the DCS were tested with the French,
Dutch and Chinese versions translated for testing. It is possible for translations to account
for some differences in psychometric testing. The “wording” of items is specifically
noted as a potential for differences in factorial validity in the Dutch translation (Koedoot
et al., 2001).
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3.4.2 SURE Screening Test.
The Sure of myself, Understand information, Risk-benefit ratio, Encouragement
(SURE) screening test was developed to be a shorter, less time intensive decisional
conflict measure as compared to the DCS. In developing a more concise measure, the
investigators hoped to provide a measure that would be clinically useful in health care
settings, especially as an efficient screening tool for decisional conflict (Legare et al.,
2010). The scale is based on the DCS and the core concepts of the Ottawa Decision
Support Framework including: feeling uncertain, feeling informed, feeling clear about
values and feeling supported in decision making (Legare et al., 2010; Legare, O'Connor,
Graham, Wells, & Tremblay, 2006). SURE scales were developed concurrently in both
French and English and were framed in such a way as to form the acronym SURE in both
languages. The SURE scale is a 4-item test in which all statements are positively worded.
Respondents answers “yes,” or “no” to each item. A score of 1 is assigned to “yes”
answers and a score of 0 is assigned to “no” answers. Scores are summed and range from
0 (high decisional conflict) to 4 (no decisional conflict). A score of ≤ 3 is indicative of
decisional conflict (Ferron Parayre, Labrecque, Rousseau, Turcotte, & Légaré, 2014;
A.M. O'Connor, 1993).
Results of reliability and validity testing for the SURE test were first published in
2010. The measure was tested in two groups of patients actively involved in making a
healthcare decision. The first group was made up of 123 French speaking, pregnant
women who were in the process of making decisions about participation in prenatal
Downs Syndrome screening. The second group was made up of 1474 English speaking
patients facing various health care decisions for chronic conditions and cancers. Fifteen
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percent of the French speaking, and 33% of the English speaking sample, had scores
indicative of decisional conflict (i.e. ≤ 3) (Legare et al., 2010).
Reliability of the SURE test may be described as moderate with Cronbach alpha of
0.54 in the French-speaking pregnant women and 0.65 in the English-speaking patients.
Removing the Encouragement item (Do you have enough support and advice to make the
choice?), resulted in an increased Cronbach alpha to 0.61 in the French-speaking
pregnant women group. Item-to-total Pearson correlation coefficients ranged from 0.32 to
0.59 with the exception of the Encouragement item which showed a very minimal
positive correlation of 0.07. Item-to-item correlations were positive, ranging from 0.46 to
0.71 with the exception of the Encouragement item which was negatively correlated with
both the Knowledge and Value items (Legare et al., 2010).
Several tests of SURE validity were completed. Before testing began, content validity
of the SURE test was “field-tested” by what Legare et al (2010) describe as experts and
graduate students taking courses in decisional support. Unfortunately, no discussion of
how the experts were recruited or exclusion/inclusion criteria was provided. Convergent
validity was assessed in the group of 123 women who completed both the DCS and
SURE. SURE scores were negatively correlated with the DCS score (Pearson r = -0.46, p
< 0.0001). The hypothesis that the SURE test scores would discriminate between patients
who had made a decision and those who had not was tested. Patients who had not made
decisions about treatment had significantly lower scores than those who had made a
decision (p < .0001). A factor analysis in the scores from the group of pregnant women
was conducted, finding two factors accounting for 72% of the variance. All items except
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the Encouragement item loaded under one factor (Legare et al., 2010). Overall, the SURE
test was acceptably valid and moderately reliable in the initial validation work.
A secondary data analysis of psychometric properties of the SURE test was published
in 2013. Six hundred fifty four primary care patients who participated in a randomized
trial assessing an intervention on shared decision making completed both the DCS and
SURE test. DCS and SURE scores were significantly correlated (Spearman’s p = -0.45, p
<0.0001) (Ferron Parayre et al., 2014).
3.5. Strengths and Limitations
A particular strength of decisional conflict scales can be found in the theoretical and
empirical background of the construct. The construct of decisional conflict is well
developed and researched and has been an accepted nursing diagnosis for over two
decades. The behavioural and minor manifestations of decisional conflict are identified as
consequences and interventions (A.M. O'Connor, 1993). According to O’Connor (1995),
the conceptual framework for the construct of decisional conflict served as the basis for
DCS development (Annette M. O'Connor, 1995). The SURE test was based on the DCS
and developed from the Ottawa Decision Support Framework of which decisional
conflict is a part (Legare et al., 2010).
The DCS scales are reported as feasible and understandable. The scale with the
greatest numbers of items is the DCS (16 items) and may take 10 – 20 minutes to
complete. The SURE test has only 4 items and is a clinical-use version of the DCS.
Testing of the scales indicates moderate to acceptable reliability with some
exceptions for subscale items. Overall, subscale and total DCS reliability testing showed
acceptable internal consistency. Moderate reliability was found with the SURE test
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(Cronbach alpha of 0.54 - 0.65 in two groups). Reliability was increased with the removal
of one item. In the current SURE test, all four items continue to be included (A.M.
O'Connor, 1993). More testing with larger samples in various populations has been
encouraged by the investigators (Legare et al., 2010). Factor analysis should be addressed
in future studies (Legare et al., 2010).
A limitation consistent to decisional conflict scales is the lack of discussion regarding
scale development; O’Connor (1995) describes item and subscale development to be
based on the construct of decisional support. Unfortunately, very little information is
provided about the development, testing and revision of items, subscales and total scale
(Annette M. O'Connor, 1995). The actual development of the particular items is not
described in detail. Cut-off scores or scores of significance are also not well described in
the literature. A score of 37.5 is reported to have meaning for the DCS scale yet an
associated reference is not provided (A.M. O'Connor, 1993).
3.6. Recommendations for New Directions in Measurement of Decisional Conflict
In regard to the psychometric properties of the decisional conflict scales reviewed and
analyzed in this manuscript, some questions remain. For the 16-item DCS, a three-, four-,
and five-dimension structure has been reported in different populations and with different
translations of the instrument. The support subscale in particular, shows variation in
reliability and factor analyses. Perhaps the targeted population for testing is an important
factor. For example, decisional conflict may be present in higher levels or may be related
to different aspects of the construct and therefore exhibit different dimensions, depending
on the nature of the population, decision being made, or the wording used for the
instrument. It seems probable that decisional conflict exhibited by someone making a
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decision about immunization could be different from decisional conflict exhibited by
someone facing a life-threatening illness and surgery. Future research should be focused
on the nature of decisional conflict in different populations and the meaning and
usefulness of all subscales across all populations.
In the population of women with early-stage breast cancer making surgical decisions,
decisional conflict should be a focus of further study. Several retrospective reviews have
investigated patient and practitioner predictors of surgical decision making. To date, very
few prospective studies of the decision-making process have been completed. Most
research in this setting which includes measurement of decisional conflict is focused on
the use of decision aids or interventions. The differences in decisional conflict scores are
assessed pre- and post-intervention but baseline information about decisional conflict in
this setting is not well-described.
3.7. Conclusion
Women with early stage breast cancer may move quickly from being part of the
“healthy” population completing cancer screening or follow-up to becoming a person
diagnosed with cancer. Surgical decisions occur rapidly and decisional conflict may
affect the decisions which are made and may affect the quality of those decisions.
Decisional conflict measurement may also be useful for interventional research in this
setting and may promote the opportunity for high-quality surgical decision making
among women with early stage breast cancer.
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Table 3.1
Characteristics of Decisional Conflict Scales
Decisional Conflict Scale
Format
Total Number of Items

Responses
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Scoring

SURE

Statement

Question

Question
Low Literacy Version

Question

16

16

10

4

Strongly Agree = 0
Agree = 1
Neither Agree nor
Disagree = 2
Disagree = 3
Strongly Disagree = 4

Yes = 0
Probably Yes = 1
Unsure = 2
Probably No = 3
No = 4

Yes = 0
Unsure = 2
No = 1

Yes = 1
No = 0

Scores are summed,
divided by 16 and
multiplied by 25.

Scores are summed,
divided by 16 and
multiplied by 25.

Scores are summed,
divided by 10 and
multiplied by 25.

Range from 0 to 100

Range from 0 to 100

Range from 0 to 100

Can only be
calculated if all are
answered
Scores are summed

Score Interpretation

Scores >37.5 indicate
high Decisional Conflict

“Do you feel sure
“Do you feel sure about
about what to
what to choose?”
choose?”
Based on information from: (Legare et al., 2010; A.M. O'Connor, 1993; Annette M. O'Connor, 1995)
Sample Items

“I feel sure about what to
choose”

Range from 0 to 4
Scores ≤ 3 indicate
high Decisional
Conflict
“Do you feel SURE
about the best choice
for you?”

Table 3.2
Summary of Reliability and Validity of the Decisional Conflict Scale (DCS)
First Author
(Year)
O’Connor
(1995)(Annette
M. O'Connor,
1995)

DCS Format

Sample

Statement Format Health science
students considering
16-Items
influenza
vaccinations (n=45)
3 Subscales
Healthcare
employees
considering influenza
vaccinations (n=115)
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Patients with cardiac
and respiratory
problems considering
influenza
vaccinations (n=283)

Koedoot
(2006)
(Koedoot et al.,
2001)

Women ages 50-69
considering breast
cancer screening
(n=360)
Statement Format Women with
metastatic cancer
16-Items
considering palliative
chemotherapy (n=29)
3 Subscales
Women with earlystage breast cancer
choosing between
mastectomy or
lumpectomy (n =

Reliability
Total Scale:
• Test-Retest correlation
coefficient (tested in health
science students) = 0.81
• Cronbach alpha ranged
from 0.78—0.92 (tested in
all groups)
Subscale Cronbach alpha:
• Uncertainty = 0.73-0.92
(tested in all groups)
• Effective decision making =
0.77-0.86 (tested in all
groups)
• Factors contributing = 0.58
(cardiac/respiratory
patients) and 0.70 (women
considering breast
screening)
Total Scale not reported

Validity and Factor Analysis
Known groups approach tested in
group of health science students
showed statistically significant
difference (p < 0.001)
Hypothesis testing conducted in the
breast cancer screening group, DCS
scores were inversely correlated to
knowledge tests about breast cancer
(Pearson r = -0.16, p<0.05)

Known groups approach showed
statistically significant difference in
Subscale Cronbach alpha (both
the metastatic cancer group for all
groups):
three subscales and showed
significant differences for the
• Uncertainty = 0.61
uncertainty (p <0.001) and factors
(metastatic cancer group)
and 0.75 (early-stage breast contributing (p <0.001) subscale
among women with early-stage
cancer group)
• Effective decision making = breast cancer
0.83 (metastatic cancer

Table 3.2 (Continued)
141)

Katapodi
(2011)

Statement Format
16-Items
3 Subscales
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O’Connor
(1993)(A.M.
O'Connor,
1993) Updated
2010
Lam
(2012)(Lam et
al., 2012)

Question Format
16-Items
5 Subscales
Question Format
16-Items
5 Subscales

Women with cancer
participating in
hereditary breast
and ovarian genetic
testing (n = 200)

Breast Cancer
Back Surgery
Hip and Knee
Surgery
PSA Testing
Newly diagnosed
breast cancer
patients, prior to
consultation with a
surgeon (n = 471)

group) and 0.81 (early-stage
breast cancer group)
• Factors contributing = 0.77
(metastatic cancer group)
and 0.83 (early-stage breast
cancer group)
Total Scale:
• Cronbach alpha = 0.96
Subscale Cronbach alpha reported
for modifications of the DCS
subscales post Factor Analysis:
• Knowledge about the
decision = 0.97
• Lack of autonomy in
decision making = 0.94
• Lack of confidence in
decision making = 0.87
Reported as “currently being tested”

Total Scale reported on a modified,
14-item version of a 3-factor scale:
• Cronbach alpha = 0.81
Subscale Cronbach alpha reported
on modifications of DCS subscales
post Factor Analysis:
• Uncertainty and Effective
Decisions = 0.71
• Informed and Values
Clarity = 0.87

Factor analysis resulted in a 4-factor
model explaining 67.5% of the
variance

Factor Analysis resulted in 3-factor
model explaining 82% of the
variance.

Reported as “currently being tested”

Known groups approach (tested on
modified 14-item DCS with 3
subscales) showed statistically
significant differences for the total
scale and all subscales
• Total Scale p <0.001
• Subscale: Uncertainty and
Effective Decisions p
<0.001
• Informed and Values
Clarity Subscale, p = 0.025

Table 3.2 (Continued)
•

Support = 0.51

•

Support Subscale, p<0.001

Hypothesis Testing:
The 14-item DCS and the modified
3-factor subscales showed positive
correlations with anxiety and
depression as measured with the
Hospital Anxiety and Depression
Scale (r ranging from 0.20 – 0.42
for anxiety and 0.20 – 0.41 for
depression, p<0.05).
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The 14-item DCS and the modified
3-factor subscales showed negative
correlation with patient satisfaction
with medical consultation as
measured by the Treatment Decision
Making Difficulties Scale (r ranging
from -0.37 to -0.52, p <.05)

Mancini
(2006)(Mancini
et al., 2006)

Format not
identified
16-Items
5 Subscales

Women with cancer
considering genetic
testing (n = 553),
control group
divided into two
samples (n = 134
and n = 125),
experimental group
(n = 294)

Total Scale:
• Cronbach alpha = 0.9050.916
Subscale Cronbach alpha:
• Uncertainty = 0.764-0.823
• Informed = 0.842-0.883
• Values Clarity = 0.67-0.703
• Support = 0.441-0.593
• Effective Decision = 0.8380.892

Factor Analysis of the 14-item DCS
resulted in 3-factor model
explaining 53% of the variance.
Factor Analysis resulted in 4-factor
model with support dimension part
of informed dimension

Table 3.2 (Continued)
O’Connor
(1993)(A.M.
O'Connor,
1993) Updated
2010
Linder
(2011)(Linder
et al., 2011)

Low- Literacy
Question Format
10-items
4 Subscales

Women with breast
cancer (n = 63)

Total Scale: Cronbach alpha = 0.86

Not reported

Low- Literacy
Question Format
10-items
4 Subscales

Men eligible for
prostate cancer
screening (n = 149)
tested at two time
intervals.

Cronbach alpha > 0.80 for total
DCS and for interclass (subscale)
correlation coefficients and for all
subscales except the Supported
subscale (Cronbach alpha = <0.60)

Known groups approach showed
statistically significant difference (p
< 0.001)
Factor analysis resulted in fourfactor model with one Support
Subscale item not loading on any
factor and another item showed
cross-loading.

Based on information from: (Koedoot et al., 2001; Lam et al., 2012; Linder et al., 2011; Mancini et al., 2006; A.M. O'Connor, 1993; Annette M.
O'Connor, 1995)

39

CHAPTER FOUR:
Factors Influencing Preference for Surgical Choice among Women with Early Stage
Breast Cancer
4.1. Introduction
A consensus conference statement was released by The National Institute of
Health in the 1990’s to address treatment of early-stage breast cancer. Multiple
prospective randomized trials comparing breast conserving surgery (lumpectomy) and
mastectomy had demonstrated no statistical difference in survival (McGuire et al., 2009).
In the statement, breast conserving surgery (BCS) was recognized as an appropriate
treatment for the majority of women with early stage disease and was deemed
“preferable” to mastectomy (National Institutes of Health, 1991, p. 394). Significant and
widespread practice adoption of BCS was expected once surgeons could allow women to
choose a breast conserving approach (Balch & Jacobs, 2009). Mastectomies continued to
be performed in substantial numbers however, ranging from 30% to over 50% of cases in
reported series (Chagpar et al., 2006; Collins et al., 2009; Nattinger, Gottlieb, Veum,
Yahnke, & Goodwin, 1992).
After the consensus statement was released, several states enacted legislation
mandating provision of information and unbiased discussion of surgical treatment
alternatives in breast cancer. Those policy initiatives were advocacy efforts undertaken to
promote informed consent with the anticipated result of increased BCS utilization. It was
assumed that if women were given the choice, they would choose BCS in greater
numbers (Lantz, Zemencuk, & Katz, 2002). Within the medical community, BCS rates
are viewed as indicators of quality (Katz & Hawley, 2007). In addition, national
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accreditation standards monitor rates of BCS, recommending that at least 50% of surgery
for all eligible, early stage breast cancer patients should be BCS (National Accreditation
Program for Breast Centers, 2017).
In recent years, increasing rates of mastectomy with contralateral prophylactic
mastectomy (CPM) have been reported among women with unilateral, early stage breast
cancer (Dragun et al., 2013; Jones et al., 2009; King et al., 2011; Tuttle et al., 2007;
Tuttle et al., 2009). The prophylactic surgery, i.e. removal of the contralateral breast,
decreases the risk of contralateral breast cancer yet confers no survival advantage
(Lostumbo, Carbine, & Wallace, 2010). If eligible for a choice between surgical options,
a woman’s decision becomes one of preference in a decision making process that is
poorly understood.
From multiple retrospective reviews of national and single-institution databases,
several predictors of the surgical choice for mastectomy with CPM have been identified.
These predictors have fallen into the categories of demographic and clinical factors.
Younger age, higher level of education, positive family history of breast cancer,
white/Caucasian/nonHispanic ethnicity, positive BRCA1 or 2 status and having a
personal history of breast cancer have been associated with the choice of bilateral
mastectomy. Tumor characteristics such as size, invasion, histology, receptor and lymph
node status have been identified as predictors (Arrington, Jarosek, Virnig, Habermann, &
Tuttle, 2009; Damle et al., 2011; Guth et al., 2012; Jones et al., 2009; King et al., 2011;
Stucky, Gray, Wasif, Dueck, & Pockaj, 2010; Tuttle et al., 2007; Tuttle et al., 2009; Yi et
al., 2009). In addition, the use of preoperative breast magnetic resonance imaging (MRI)
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and genetic counselling have been associated with the choice of mastectomy with CPM
(King et al., 2011; Sorbero, Dick, Beckjord, & Ahrendt, 2009; Stucky et al., 2010).
In retrospective reviews using surveys and interviews with women after surgical
treatments have been completed, factors of a more personal nature have been identified.
Fear or worry about recurrence and second breast cancer, distress and anxiety have been
described as important, and in some studies, as associated with the choice of bilateral
mastectomy (Beesley, Holcombe, Brown, & Salmon, 2013; Han et al., 2011; Hawley et
al., 2014; Jagsi et al., 2017; Pedersen et al., 2010; Rosenberg et al., 2015; Rosenberg et
al., 2013; Soran et al., 2015; Spittler, Pallikathayil, & Bott, 2012). Quality of life issues
such as body image and concerns about cosmetic surgical outcomes have also been
described as part of this preference-sensitive treatment decision (Baptiste et al., 2017;
Beesley et al., 2013; Buchanan et al., 2016; Fisher et al., 2012; Spittler et al., 2012). In
addition, women have identified desire to avoid radiation therapy and more frequent
medical visits as part of their reasons for choosing mastectomy with CPM (Baptiste et al.,
2017; Fisher et al., 2012; Han et al., 2011). Factors as yet unknown may contribute to
surgical decision-making. Studies using prospective designs may provide needed
information. The purpose of this exploratory study is to prospectively identify
demographic, clinical, cognitive and affective factors influencing a woman’s decision to
choose either breast conserving surgery (BCS) or mastectomy with CPM and to identify
self-reported sources of information in the surgical decision-making process.
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4.2. Research Questions
The following research question will be addressed: What factors influence a
woman’s choice between two surgical options, BCS and mastectomy with CPM
following a diagnosis of early stage breast cancer and prior to surgical treatment?
Specific research aims are: 1) to examine differences between women choosing
two surgical options (breast conserving surgery and mastectomy with CPM) related to the
following factors: demographics, diagnostic processes, tumor characteristics, depression,
anxiety, stress, distress, breast cancer specific distress and decisional conflict, 2) to
examine differences in breast surgery beliefs and expectations between women choosing
between the two surgical options and, 3) to identify information sources important to
women in the decision-making process.
4.3. Conceptual Framework
The Ottawa Decision Support Framework, a conceptual model for shared decision
making, served as an organizing framework for this study. In the model, the desired
outcome of shared decision making is a quality decision, described as one based on both
the best scientific evidence and on patient values. Positive outcomes such as minimized
decisional delays and post-decisional regret are purported to result from quality decisions.
Within the framework, participants in the decision making process have decisional needs
which may include conflict, expectations, and specific personal and clinical
characteristics (Ottawa Hospital Research Institute, 2015). Decisional needs are
modifiable with decision support interventions that provide information, clarify needs
and values, and facilitate progress (Légaré, O'Connor, Graham, Wells, & Tremblay,
2006).
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4.4. Study Design
This prospective, exploratory, cross-sectional, mixed-methods study was designed to
gather information during the time period in which surgical decision-making occurred.
Both participant self-report and medical record information were collected. The study
was approved by the Baptist Health Lexington Institutional Review Board and oversight
agreement was given by the University of Kentucky Office of Research Integrity.
Immediately prior to enrollment, women were examined by a breast surgeon and
completed a surgery decision-making consultation visit with the surgeon and breast
cancer nurse navigator. Enrollment in this manner allowed confirmation of early stage
disease. In addition, eligibility for choice among the surgical options was confirmed by
the surgeon. Other inclusion criteria included unilateral breast carcinoma, older than 18
years of age, able to read and understand English and with no personal history of cancer
with the exception of non-melanoma skin cancer.
4.4.1 Sample and setting.
An a priori power analysis was conducted. Based on a moderate effect size of 0.5,
alpha of 0.05 and power of 80%, a sample size of 128 was planned, 64 in the group
choosing BCS and 64 in the group choosing mastectomy with CPM. Enrollment began in
August 2016 and continued to August 2017 (n = 112). Sixteen participants (14%) did not
return completed questionnaires. Eight chose unilateral mastectomy and were excluded
from this analysis. Ten (9%) were ineligible after enrollment: two participants had a
prior history of cancer and were inadvertently enrolled, one completed the survey after
surgery was completed, and eight were subsequently found on further workup to have
either bilateral breast cancer, locally advanced Stage III disease or multifocal disease
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making them ineligible. For analysis, n = 78 including 47 in the BCS group and 31 in the
bilateral mastectomy (BM) group. All other parameters remaining the same, a repeated
power analysis of these unequal groups reveals a post-hoc power of 57%. Less than 5%
of those invited declined to participate.
The setting for the study was a 391-bed community hospital and an affiliated,
seven-surgeon group office practice. Patients were eligible for enrollment consecutively,
on the day of consultation with the breast surgeon and immediately after the surgical
decision-making conference occurred with the breast surgeon and breast nurse navigator.
A study investigator approached potential participants in a private area of the physician
office to explain the study and obtain informed consent to participate. If a surgical
decision had been made, enrolled patients were offered the option to complete the study
packet at that time and were given a $10.00 gift card. If a surgical decision had not been
made at that point or as the patient requested, participants were provided with the packet
and a stamped, postage-paid return mailing envelope. Verbal and written instructions
were provided including a reminder to complete the study packet after a surgical decision
was made but prior to the surgery. The principal investigator tracked enrolled
participants who had not returned packets and completed a minimum of one reminder
telephone call to participants as needed. Instruction to complete the packet after a
decision had been made and prior to surgery was included in reminder phone calls.
Participants completing and returning packets were provided with a $10.00 gift card
mailed to the participant in a self-addressed envelope.
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4.4.2 Variables and measures.
Participants were given a packet that contained: demographic questionnaire, items
pertaining to Gail risk calculation, Depression Anxiety Stress Scale, Impact of Event
Scale, Decisional Conflict Scale, Breast Surgery Beliefs and Expectations Scale, list of
Information Sources, open-ended prompt and question about intention (Appendix). This
packet could be completed in approximately 15 – 20 minutes. Medical record
information was abstracted from the electronic medical record by the principal
investigator.
4.4.2.1 Personal, demographic and clinical information.
The following demographic information was retrieved from participants: age,
race, marital status, level of education, employment status, income level, insurance status,
personal and family history. Clinical information was collected from the medical record
and included: breast imaging information including MRI and post-MRI biopsies, genetic
counselling consultation, genetic testing results and pathologic features of surgical
specimens including tumor prognostic indicators such as receptor status, histology and
grade.
4.4.2.2 Depression, Anxiety and Stress Scale.
The Depression Anxiety Stress Scale (DASS) consists of a total of 42 items to
which respondents are asked to signify an answer on a four-point scale ranging from 0
(did not apply to me at all) to 3 (applied to me very much or most of the time).
Participants are asked to include experiences from the preceding week when responding.
Fourteen items of the DASS pertain to depression, 14 to anxiety and 14 to stress and
items for each of these three subscales are interspersed among the other subscale items.
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Reported mean scores in a normative, non-clinical sample include: total score M= 18.38
(SD = 18.82), depression subscale M = 5.55 (SD = 7.48), anxiety subscale M = 3.56 (SD
= 5.39) and stress subscale M= 9.27 (SD = 8.04). Higher scores represent higher
depression, anxiety and stress on the representative subscale and overall distress for the
total score. Levels of symptom severity have been established with severe levels defined
as: depression score > 20, anxiety score > 14 and stress score > 26 (Crawford & Henry,
2003).
The DASS has been found to have high reliability in prior studies. Cronbach
alpha for the overall DASS have been reported in the range of 0.84-0.97 for the total
DASS and for the three subscales (Crawford & Henry, 2003; Lovibond & Lovibond,
1995). In this study reliability was high, with coefficient alpha ranging from 0.86-0.96
for the overall and three DASS subscales.
4.4.2.3 Impact of Event Scale.
The Impact of Event Scale (IES) is a self-report measure of distress associated
with a serious life event. With identification of a specific event within the instructions
for completing the IES, the scale was linked with the personal experience of breast cancer
for each participant. Fifteen questions are divided among two subscales, intrusion and
avoidance. The intrusion subscale contains seven items and the avoidance subscale
contains eight items. Each item asks the respondent to consider how frequently the item
was true in the past seven days. Items are rated on a four-point Likert scale ranging from
“not at all,” “rarely,”, “sometimes,” to “often.” Items are scored as 0, 1, 3, and 5
respectively. The resulting range of scores for each scale is 0 to 35 for the intrusion
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subscale and 0 to 40 for the avoidance subscale (Epping-Jordan et al., 1999). Higher
scores represent higher breast-cancer specific distress.
Acceptable reliability has been reported with the IES. In the breast cancer
population specifically, coefficient alpha levels of 0.90 for the total scale, 0.70-0.71 for
the intrusion scale and 0.83-0.85 for the avoidance subscale have been reported (EppingJordan et al., 1999; Miller, Schnur, Weinberger-Litman, & Montgomery, 2014). In this
study, acceptable coefficient alpha was 0.93 for the IES total, 0.89 for the intrusion
subscale and 0.87 for the avoidance subscale.
4.4.2.4 Decisional Conflict Scale.
The Decisional Conflict Scale (DCS) consists of 16 total items in statement
format. Responses are made using a five point Likert scale ranging from 0 (strongly
agree) to 4 (strongly disagree). Responses are summed, divided by 16 and then
multiplied by 25, resulting in a decisional conflict score ranging from 0 to 100. Low
scores represent low decisional conflict and high scores represent high decisional
conflict. Scores above 37.5 are associated with feeling unsure about the decision and
with decisional delay (O’Connor, 1995). Coefficient alpha for the scale in previous
studies ranges from 0.78—0.92, demonstrating acceptable internal consistency
(O’Connor, 1993). The five subscales of the DCS include: informed, values clarity,
support, uncertainty and effective decision. Three items make up each subscale except
for the effective decision subscale which is comprised of four items. High subscale
scores represent high decisional conflict in that specific area.
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4.4.2.5 Breast Surgery Beliefs and Expectations Scale.
In order to assess the way in which women think about breast surgery options, a
measure of the beliefs and expectations was developed. Items for the scale were drawn
from the primary investigator’s clinical experience and from previous published
assessments of disease-specific knowledge (Collins et al., 2009; Fagerlin et al., 2006;
Sepucha, Ozanne, Silvia, Partridge, & Mulley, 2007). The Breast Surgery Beliefs and
Expectations Scale (BS-BES) included nine items to which participants were asked to
assign a level of importance using a Likert scale ranging from 1 (not at all important) to 4
(very important). Higher scores on each item represented higher importance of that item
in the surgical decision.
The BS-BES was reviewed by three oncology nurses prior to use. A breast cancer
nurse navigator, oncology clinical nurse specialist and oncology nurse read the items to
evaluate clarity, measurement format and with consideration of the scale’s intent.
Revisions were made for clarity and concision.
4.4.2.6. Information sources.
Participants were asked to identify sources of information in their surgery
decision-making process. A list of information sources was developed from the
investigator’s clinical experience and from published reports (Covelli, Baxter, Fitch,
McCready, & Wright, 2014; Dickerson, Alqaissi, Underhill, & Lally, 2011; Lally, 2009;
Spittler et al., 2012). Women were provided an opportunity to add sources not found on
the list and asked to delineate the most influential source among their list.
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4.4.2.7 Intention.
Intention to choose either BCS or mastectomy with CPM was assessed using a
single question. Participants were asked to respond “yes” or “no” to the question, “Did
your initial intent regarding surgery match your final decision?”
4.4.3 Open-ended prompt.
Given the lack of prospective studies, the opportunity to explore personal, selfgenerated information was important. An open-ended prompt asking for comments about
the reason for the surgical choice was provided.
4.5. Data Analysis
Data analysis was performed using IBM SPSS® Statistics (version 24).
Frequency distributions were used to examine all variables including outliers and
distributions. Descriptive statistics including means, standard deviations and frequency
percentages were used to characterize the total sample and both subgroups as appropriate.
Categorical and continuous level data for demographic, clinical and diagnostic
characteristics as well as information sources and intention were analyzed using
independent sample t-tests and chi-square tests as appropriate to the level of data. Oddsratios were calculated. For those categorical variables in which cell counts were less than
five, Fisher’s exact test was used to compare groups.
Total scores and subscales scores of the DASS, IES and DCS for each group were
compared. Independent t-tests were used to compare total scale and subscale data. Given
the exploratory nature of this study a Bonferroni correction was not calculated.
Factor analysis was performed on the investigator-designed BS-BES to evaluate
the shared variance of the nine items. The factor analysis provided the basis for
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identifying three subscales within the instrument. Suitability assumptions for factor
analysis were met in number of response options of at least three and ten cases per item.
The sample size was 77 for this scale, which is below the minimum recommended for
factor analysis. Bartlett’s test of sphericity was used to test the correlation matrix and
Kaiser-Meyer-Olkin (KMO) was used to evaluate matrix sample adequacy. A KMO
value greater than 0.5 was considered minimally acceptable. Principal component
analysis extraction with varimax rotation was performed. Items were identified to a factor
with loadings greater than 0.40. Cross-loaded factors were defined as those loading on
more than one factor.
4.6. Results
4.6.1 Research Aim 1: To examine differences between women choosing two
surgical options (breast conserving surgery and mastectomy with contralateral
prophylactic mastectomy) related to the following factors: demographics,
diagnostic processes, tumor characteristics, depression, anxiety, stress, distress,
breast cancer specific distress and decisional conflict.
4.6.1.1 Demographic, diagnostic and clinical factors.
Demographic characteristics of the sample and subgroups are summarized in
Table 4.1. The participants were 57 (SD 12) years of age on average, almost exclusively
Caucasian (94%), and the majority were married/partnered (66%). The majority of
participants had an education level greater than a high school education with 49%
completing some college or university study and 20% completing some graduate level
education. Sixty percent of participants were employed full- or part-time and 77%
reported an income level greater than or equal to, $40,000 per year. Only four women in
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the study reported having Medicaid and all of those women elected to have BCS. A
statistical comparison of groups was not able to be completed for insurance status due to
distribution of this variable.
A significant difference was found for age (t(77) = 5.098, p < .001, r = .59) and
employment (χ2 (1) = 3.78, p < .05) between women choosing BCS and women choosing
mastectomy with CPM. Women choosing mastectomy with CPM were 12 years younger
on average (M 50, SE = 1.9) as compared to those choosing BCS (Μ 62, SE = 1.5).
Those who worked either full or part-time were 2.6 times more likely to choose bilateral
mastectomy. There were no differences in race, marital status, education level and
income.
Diagnostic factors are shown in Table 4.2. The total sample was evenly divided
between those who did and did not complete preoperative breast MRI. In comparing the
groups however, different distributions are seen with 60% of women in the BCS group
and 35.5% of women in the bilateral mastectomy group completing preoperative imaging
with breast MRI. The majority of participants (58%) did not complete genetic counseling
but distribution differences in the subgroups are again noted. In the BCS group, 28%
completed genetic counseling and in the mastectomy with CPM group, 64.5% completed
genetic counseling. The majority of the total sample and each subgroup did not require a
post-MRI biopsy, did not have genetic testing, did not have a family history in first
degree relatives and were not defined as high-risk prior to diagnosis as calculated by the
Gail risk model.
Statistically significant differences were found between the groups for
preoperative breast MRI and genetic counseling. Among those who did have
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preoperative breast MRI, women were 2.68 times more likely to choose BCS, χ2 (1) =
4.336, p < .05 and among those who had preoperative genetic counseling, women were
4.8 times more likely to choose bilateral mastectomy as compared to BCS χ 2 (1) =
10.396, p < .01 (Table 4.2).
Clinical characteristics are shown in Table 4.3. The mean tumor size was 1.5 cms
(SD 1.2) in largest dimension. Those choosing bilateral mastectomy had tumors
averaging 2.2 cms in largest dimension as opposed to an average size of 1.1 cm in the
BCS group, t(76) = -4.343, p < .001, r = .4. Tumor size was the only variable with a
significant difference between the groups in terms of clinical characteristics. Most tumors
were invasive or in situ ductal carcinomas (91%), lymph node negative (74%), ER/PR
positive (95/96%) and HER2-neu negative (72%).
4.6.1.2 DASS, IES, and DCS Scores and Subscale Scores.
The properties of DASS, IES and DCS scales and subscales are outlined in Table
4.4. Cronbach coefficient alpha > 0.70 was considered acceptable. All scales and
subscales met criteria for acceptable reliability with the exception of the uncertainty DCS
subscale (α = 0.67).
Overall, mean DASS total scores and subscores were within the normal range
criteria (Table 4.4). Only six (8%) and nine (12%) participants reported greater than
moderate levels of depression and anxiety, respectively. No participants reported stress
above moderate levels (Table 4.5).
Breast cancer specific distress measured by the IES, resulted in the following
mean scores for the sample as a whole (Table 4.4): IES-total (M = 28.20; SD 18.54),
IES-Intrusion (M = 13.52; SD 9.49) and IES-Avoidance (M = 14.59; SD 10.17). Scores
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greater than 26 indicate a stress impact in the moderate to severe range (Horowitz, 1994).
The two items with the highest proportion of “sometimes” and “often” scores were items
four, “I had trouble falling asleep or staying asleep because of pictures or thoughts about
it that came into my mind” and five, “I had waves of strong feelings about it.” Twentytwo and 19 women reported sometimes and often experiencing items four and five
respectively. Among all participants, 39 (50%) demonstrated a moderate to severe
impact from the breast cancer diagnosis (IES score > 26). A greater percentage of
women reported an IES score 26 or above in the mastectomy with CPM subgroup (58%)
as opposed to the BCS group (45%).
The total DCS score (M = 9.10; SD 12.62) was low; well below the 37.5 score
indicative of decisional delay or insecurity with the decision. DCS subscales scores were
all low with the highest score noted on the Uncertainty Subscale (M = 14.85; SD 17.29)
(Table 4.4).
DASS, IES and DCS total scores and subscale scores for the subgroups, women
choosing BCS and women choosing mastectomy with CPM were compared (Table 4.6).
DASS and IES scores were higher on average for women in the bilateral mastectomy
group as compared to those in the BCS group. DCS total and subscale scores, with the
exception of the uncertainty subscale, were the opposite. Women in the BCS group had
higher total decisional conflict and had higher DCS subscale scores with the exception of
the uncertainty subscale for which women in the bilateral mastectomy group had higher
mean scores.
Statistically significant differences with small to medium effect size were found
in DASS Anxiety Subscale and in the intrusive impact of the diagnosis as measured by
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the IES-Intrusion subscale. Women in the mastectomy with CPM group were more
anxious on average (M = 7, SE = 0.7) than women choosing BCS (M = 4, SE = 0.7),
t(75) = -2.298, p < .010, r = .25. Breast cancer specific distress as measured by the IESIntrusion Subscale, was higher in the group choosing mastectomy with CPM (M 17, SE
1.7) as compared to those choosing BCS (Μ 11, SE 1.2), t(75) = -2.852, p < .01, r = .31.
Decisional conflict was higher among women choosing BCS. Statistically
significant differences between the two subgroups were found for the DCS scale as a
whole and for the values clarity, support and effective decision subscales. Effect sizes
were small. Mean decisional conflict scores for women choosing BCS were 10 (SE =
2.2) as compared to mean scores of 8 (SE = 1.4) for those choosing mastectomy with
CPM, t(76) = 0.9, p < .05, r = .10. Women choosing BCS were more unclear about
personal values in the decision making (M 7, SE = 2.6) as compared to those choosing
mastectomy with CPM (Μ 4, SE = 2.1), t(76) = 1.613, p ≤ .05, r = .18. They also felt
more unsupported in their decision making (M 7, SE = 2.1) as compared to those
choosing mastectomy with CPM (Μ 4, SE = 1.4), t(76) = 1.230, p ≤ .05, r = .14. Women
choosing BCS reported higher scores for ineffective decisions (M 10, SE = 2.3) as
compared to those choosing bilateral mastectomy (Μ 6, SE = 1.6), t(76) = 1.340, p ≤ .05,
r = .15.
4.6.2 Research Aim 2: To examine the differences in breast surgery beliefs
and expectations between women choosing two surgical options (breast conserving
surgery and mastectomy with contralateral prophylactic mastectomy).
The BS-BES was an investigator-designed scale, used for the first time in this
study. A summary of all responses to the nine-item scale is provided in Table 4.7. Over
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80% of participants rated the items “minimize the chance of breast cancer coming back”
and “minimize the chance of dying from breast cancer,” as very important. Forty-nine
and 47% of participants rated the item “avoid the need for future mammograms/breast
screening” and “have the option to improve my breasts through reconstruction” as not at
all important.
A factor analysis was conducted for the nine-item scale, which met requirements
for number of response criteria and number of cases per item. Bartlett’s test of sphericity
was significant (p < .001). The null hypothesis that the correlation matrix is an identity
matrix is rejected. Minimal matrix sample adequacy was met (KMO = .636) and the
determination of the correlation matrix was adequate (.077).
Factor Analysis with Varimax Rotation was performed. A cut point of .40 was
used to define factor loading and cross-loaded factors were defined as those which loaded
similarly on more than one factor. Three factors are represented in the subscale (Table
4.8), a Mastectomy Factor (Factor 1), a Recurrence/Survival Factor (Factor 2) and a BCS
Factor (Factor 3). The Mastectomy Factor is made up of four items: “remove breast for
peace of mind,” “avoid radiation,” “avoid the need for future mammograms/breast
screening,” and “have the option to improve my breasts through reconstruction.” The
Recurrence/Survival Factor is made up of two items, one about minimizing the chance of
recurrence and one about minimizing the chance of dying from breast cancer. The BCS
Factor consists of two items related to the choice of BCS, “do as little surgery as
possible” and “keep my breast.” One factor of the nine, “minimize the length of
treatment,” crossloaded on both the Mastectomy Factor and the BCS Factor and was
removed from analysis.
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Higher scores represent higher importance for each item on this scale. Higher
factor scores, therefore represent higher importance for that factor. Scores for each factor
were compared across subgroups. Significant differences were found in all three
comparisons. Mastectomy factor scores were greater for women choosing bilateral
mastectomy (M 12, SE .5) than those choosing BCS (M 7, SE .5), t(75) = -6.240, p <
.001, r = .58. Recurrence/Survival Factor scores were also higher among women
choosing bilateral mastectomy (M 7.96, SD 0.2) than those choosing BCS (M 7.29, SD
1.2), t(75) = p < .001, r = .24. In contrast, BCS Factor scores were higher among women
choosing BCS (M 5, SE .25) than among women choosing bilateral mastectomy (M 4, SE
.26), t(75), p < .01, r = .29.
4.6.3 Research Aim 3: To identify information sources important to women
in the decision-making process.
Sources of information identified by participants are shown in Figure 4.1
(percentage of all participants) and Figure 4.2 (percentage of each subgroup participants).
One hundred percent of the participants in this study identified their surgeon as an
information source in the decision-making process. The top five information sources (by
%) were similar between the two groups. For the BCS group, the top five were: 1)
surgeon, 2) family, 3) nurse navigator, 4) friends and 5) spouse/partner. For the bilateral
mastectomy group, the top five were: 1) surgeon, 2) nurse navigator, 3) family, 4)
spouse/partner and 5) friends. Nine women choosing BCS wrote in an additional
information source. The breast MRI was added as an information source by three
women. Genetic counselling, medical oncologist, “God/Jesus/Prayers,” and “other breast
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cancer survivors,” and “myself” were each added by one participant. No additional
information sources were provided by women choosing mastectomy with CPM.
Participants were asked to identify the most influential information source among
those identified. Spouse/partner and family categories were collapsed into one category
for analysis. There were significant differences between the groups identifying the most
influential information source (Table 4.9). The odds of a woman with early stage,
unilateral breast cancer choosing BCS were 6.4 times more likely if she identified the
surgeon as the most influential, X2 (1) = 10.397, p < .05. The odds of a woman with the
same diagnosis choosing mastectomy with CPM were 4.1 times more likely if she
identified spouse and family as the most influential, X2 (1) = 5.964, p < .05.
4.6.4 Intention
On the questionnaire, a yes/no question was asked regarding intention, “did your
initial intent regarding surgery match your final decision?” Sixty-one (78%) of the
participants answered “yes” to that question. There was no statistically significant
difference between the groups as analyzed by chi-square.
4.6.5 Comments
Participant comments were invited with the prompt, “In your own words, please
describe the reason for your surgical choice.” All participants provided at least one
handwritten response. Comments were extracted verbatim and compiled into lists sorted
by breast surgery. Three reviewers, two of whom have extensive clinical experience with
breast cancer patients and one of whom has an oncology research background with
expertise in both qualitative and quantitative methods read all comments. Initially,
comments were examined independently by the reviewers as main ideas were identified
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and comments were sorted accordingly. Reviewers then met and discussed common and
discrepant groupings until agreement was reached.
Among the 31 women in this study who chose mastectomy with contralateral
prophylactic mastectomy, the most common reason cited for surgical choice was worry
about recurrence and the “peace of mind” gained by the choice. Twenty-three women
described their decision in those ways including comments such as: “I wanted to not
worry the rest of my life,” “I’m only 40, and already worried that it would come back, “I
want peace of mind to know I’m doing everything I can to ensure that I beat it.” Eight
women wrote of their concern for family as a reason for their choice with comments
including, “I have two small children and want to be here to watch them grow up. I know
having me here is more important to myself, my spouse, and my children than having
breasts” and “anything I can do to minimize having to put my family and me through this
again is worth it.” Eight women identified avoidance of future surveillance as a rationale,
writing “I do not want my life to revolve around worry and mammograms in the future,”
“no fear of a bad mammogram,” and “I don’t want to have to be watched closely with
mammograms.” A family history was reported as a reason for the decision by five
women.
Less than five comments were reported in the following categories: maximizing
survival, getting rid of the cancer, making the decision to achieve a better cosmetic
outcome and as a means of avoiding radiation treatment. Three women wrote of the
relative importance of their breast with such comments as: “no real attachment to
breasts,” “breasts don’t define who I am or enhance/diminish my self-worth,” and a
woman who was a below the knee amputee commented “I’m OK losing another body
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part.” Two women reported previous issues with pain and discomfort in both breasts as a
reason for the decision to choose bilateral mastectomies.
Among participants choosing breast conserving surgery, the overwhelming
majority of comments included very clinical information. Included in this group of 23
comments were references to the histology and stage of the individual’s cancer such as
“cancer is in situ and not invasive.” There were also comments about survival and
recurrence statistics such as “the ten year prognosis between lumpectomy and
mastectomy was no different” or “the survival rate is the exact same for each.” Breast
MRI and genetic testing results were also included in that category. Fourteen comments
made reference to the advice of, or consultation with, physicians including: “The surgeon
explained the pros and cons of all procedures and it was best for my situation,” “primary
care physician and surgeon both gave same advice,” “it just makes sense to take medical
advice from physicians I trust,” and “the surgeon convinced me that lumpectomy would
be as effective with only a small chance of the cancer returning.” Breast conserving
surgery was described as a means to maintain normalcy or return to normal more quickly
and as the least invasive approach by 14 study participants. Eight women specifically
wrote about the desire to preserve their breast. Five women wrote about choosing breast
conserving surgery now with the idea that a mastectomy could be done later, for example,
“if this cancer comes back and we have to do more radical surgery,” and “my surgeon let
me now that I could change my mind about having a mastectomy at a later date if the
cancer comes back.” Two women in this group referred to mastectomies as scary and
one woman used the term “creepy.”
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There were differences in comments between the groups. While both groups
commented about their decision as pertaining to issues with recurrence of disease, the
focus was different. Those choosing mastectomy with contralateral prophylactic
mastectomy wrote about recurrence in connection with emotional terms like worry and
seeking peace of mind. The breast conserving surgery group wrote about recurrence risk
in a very cognitive way, citing percentages and specific clinical information and medical
rationale. As it pertained to lifestyle and family, rationale for the surgical choice was
also dissimilar with women in the bilateral mastectomy group focused on avoiding future
issues for their family and the breast conserving group writing about a short recovery
time and quick return to normal life now. Avoiding radiation or avoiding future
mammograms were reported as rationale in the bilateral mastectomy group and the breast
conserving surgery group conversely chose a surgery committing to both. In the breast
conserving surgery group, comments about a physician’s advice or counsel were common
and physicians were rarely mentioned by women in the other group. An unexpected
rationale for bilateral mastectomies was breast pain and very few women choosing
mastectomies spoke about cosmetic rationale such as symmetry or reconstruction.
4.7. Discussion
This study demonstrated differences between women choosing among two
surgical options as treatment for early stage breast cancer. Age was significantly
different between the two groups with younger women more likely to choose mastectomy
with CPM. This is consistent with findings from previous studies (King et al., 2011;
Tuttle et al., 2007; Tuttle et al., 2009). A reason may be the way in which women of
different ages view recurrence risk and the requisite surveillance activities post-surgery.

61

Women choosing BCS, for example, have elected to preserve breast tissue and therefore
have a local recurrence risk greater than women who have elected to have mastectomy.
Women choosing BCS will be scheduled to participate in breast cancer surveillance
activities (i.e. mammograms). Choosing bilateral mastectomy decreases the risk of local
recurrence significantly and relieves the woman of future surveillance by breast imaging.
Mammograms from younger women with greater breast density are more difficult to
evaluate. Recall for diagnostic films and false positive findings are more common for
that reason. Younger women may be familiar with that issue already and may choose
mastectomy in response. Age differences may be important in light of family and work
concerns. Women who have young children in the home or who are establishing
themselves in the workforce may view the surgical options and recovery periods
differently than women with older or adult children who are more established in their
careers.
The majority of women in both subgroups were employed either part- or fulltime. A meaningful finding in this study was a difference between the subgroups in
terms of employment. This finding is new in this area, perhaps because employment
status is not included in cancer registry data and could therefore not be tested in
retrospective studies drawn from cancer databases.
Participation in genetic counseling and preoperative breast MRI were both
significantly different between the groups. Participation in genetic counseling has been
identified in previous studies as predictive of choosing mastectomy with CPM (Soran,
Kamali Polat, Johnson, & McGuire, 2014; Stucky et al., 2010) which is consistent with
findings in this study. Higher rates of CPM have been associated with preoperative
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breast MRI in previous studies (Sorbero et al., 2009; Stucky et al., 2010). In this study,
however, women who had preoperative breast MRI were more likely to choose BCS.
This may be a result of changing practice patterns in the use of breast MRI. In the setting
in which this study was conducted, breast MRI is often recommended for women prior to
BCS to assess for multifocal and bilateral disease before undertaking a conservative
surgical approach. Women choosing mastectomy with CPM do not need to undergo
breast MRI because concerns about re-excision for positive margins or diffuse multifocal
disease are not relevant.
The prospective design of this study allowed for observation of something not
previously reported regarding breast MRI. In this study, eight of the 112 participants
were excluded from the study after positive findings on breast MRI. Those eight women
who had been diagnosed with early stage cancers no longer met immediate eligibility
criteria for a choice among surgical options. Retrospective studies are unable to gather
this level of data and previous studies finding associations between breast MRI and
bilateral mastectomy may include patients who are truly not eligible for a breast
conserving approach after breast MRI.
Overall levels of distress, depression, anxiety and stress were within normal levels for
the participants. This may be related to the baseline characteristics of an educated,
insured, higher socioeconomic group of women who have support from spouses/partners.
There was some variability in these measures within the sample, however with some
women exhibiting high levels of distress, depression and anxiety and breast cancerspecific distress in both subgroups. Significant differences between the two groups were
seen for generalized measures of anxiety and for the intrusive impact of the breast cancer
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diagnosis; those choosing mastectomy with CPM exhibited higher levels of both as
compared to women choosing BCS. The lack of previous, prospective studies in this
population provides very little comparison. Higher perceived risk for contralateral breast
cancer has been associated with higher levels of anxiety in one study (Portschy et al.,
2015). In a prospective study of women with early and locally advanced, newly
diagnosed breast cancer, total IES scores were not significantly associated with CPM.
Subscale IES scores were not reported in that study (Parker et al., 2016). Exploration of
those affective factors are possible in a study of this design and the differences between
the groups are new findings.
Overall, the participants exhibited low decisional conflict. In the breast conserving
surgery group, mean DCS scores were higher and standard deviations were wider
suggesting higher and more varied decisional conflict as compared to women in the
mastectomy with CPM group. Significantly higher decisional conflict was seen in the
BCS group as compared to women choosing bilateral mastectomy. In addition, women
choosing BCS expressed greater lack of values clarity and support in their decision
making and expressed higher levels of conflict in terms of effective decision-making.
Among women electing mastectomy with CPM, previous reports have described high
satisfaction, low decisional conflict and low decisional regret with the decision
(Buchanan et al., 2016; Lally, 2009; Mamtani & Morrow, 2017; Moffat & Yakoub, 2016;
Soran et al., 2014)
A scale was developed for this study to assess women’s beliefs and expectations
about surgery options for breast cancer. This is the first use of the scale; validity and
reliability testing is warranted. Factor analysis identified three dimensions in the scale
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which were used to test differences between the groups. The groups differed
significantly for all three factors. Woman choosing mastectomy with CPM reported
higher importance on the mastectomy factor, women choosing BCS reported higher
importance on the BCS factor, and women choosing mastectomy with CPM reported
higher importance on the recurrence/survival factor. One item on the BS-BES scale
crossloaded on both mastectomy and BCS factors. This was unexpected. The item,
“minimize the length of treatment” appears to have been interpreted differently among
the participants. It was intended to be a measure predictive of bilateral mastectomy
choice in that mastectomy would alleviate the need for a post-surgical course of radiation
therapy and future breast surveillance. Participants interpreted the item differently which
is perhaps explained by comments from women in the BCS group who reported quicker
recovery time and return to normal as rationale for their choice of BCS. Multiple
reconstruction procedures may have been considered “treatment” by participants.
In both groups, the majority of women reported choosing the surgery they had
originally intended to choose. This might be related to the fact that no unexpected
findings occurred with their workup, therefore recommendations and options remained
stable and as expected. It could also reflect a commitment to a choice made prior to
consultation with the surgeon as was found in a qualitative study of women in the
surgical decision-making process. In that study, some women were found to have
preferences about surgery choice that were made prior to the surgical consultation (Lally,
2009).
All of the participants in the study, no matter the subgroup, identified the surgeon
as an information source. Information sources were similar between the two groups with
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the same top five sources identified by both groups. An unexpected finding was the
identification of the 6th choice for both subgroups, a professional from the breast imaging
area. The mastectomy with CPM group identified a breast imaging nurse and the BCS
group identified a breast imaging radiologist as an information source. This has not been
reported previously and brings a new perspective to the surgical decision making process.
The role of breast imaging professionals in this process should be further explored and
defined. Breast imaging may be an area in which decisional support counselling and
resources could be focused.
In regard to the designation of the most influential information source, subgroups
differed. The surgeon was chosen as most influential in the BCS group and
spouse/family were chosen as most influential in the bilateral mastectomy group. This
finding could be relevant in research studies and implementation of decisional support
interventions. The identification of family as the most influential information source
points to the importance of decisional support that would include the family.
When asked to provide comments about the reason for their surgical choice, all of
the participants in the study responded. Some participants replied with more than one
page of comments. Categories of comments provided a contrast between the groups.
Recurrence was mentioned by both groups as important in their decision making but the
way in which it was expressed was different. Women in the bilateral mastectomy group
wrote about recurrence in more emotional terms, associated with words like worry, fear
and “peace of mind.” They also expressed their surgical decision as one that was more
future-oriented in reducing the risk of breast cancer coming back. Women in the BCS
group wrote about recurrence in association with medical information about their disease
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specifically and about chance or odds. They were more oriented to the present time,
writing of a quicker return to normal or aversion to more extensive surgeries or even
multiple reconstructive surgeries.
Comments provided new information in the rationale for mastectomy related to a
history of breast pain and very few women commented on a cosmetic rationale for
choosing bilateral mastectomy. A new insight into the choice of BCS was highlighted in
comments about going through BCS first with the option of mastectomy later. It could be
presumed that the larger tumor size in the group of women choosing bilateral mastectomy
might have led more women to choose the procedure because of cosmetic outcomes
which may have been less positive with larger resections. As evaluated by the lack of
comments about cosmetic rationale, this does not appear to be the case.
Comments also provided information which was used in data analysis and
interpretation. Women in the BCS group overwhelmingly wrote about the influence of
the surgeon in their surgical choice while very few women in the mastectomy with CPM
group commented about the surgeon. The difference informed the comparison of groups
by the information source they chose as most influential.
4.8. Limitations
This study was conducted in one community hospital. The sample lacked
diversity in terms of race/ethnicity, socioeconomic and insurance status. Generalizations
to other populations are a limitation. Similarly, the healthcare setting in which this study
was carried out may have specific procedures, standards of care or staff which may be
unlike breast cancer care in other settings which would also limit generalization of
findings.
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4.9. Implications for Nursing
Knowledge regarding predictors of decision making among women with early
stage breast cancer is limited. Research thus far has been largely retrospective and
descriptive in nature. Given the personal nature of this decision, with resulting effects on
a woman’s body, lifestyle and emotions, the way in which women think and feel about
the decision warrants exploration. Prospective research, studies that are qualitative in
nature and particularly those that allow the opportunity to explore questions more fully
may provide much needed information about why women choose mastectomy with CPM
or BCS.
Patient decision making is optimized when knowledge is increased and
participation is satisfactory to the patient (Katz & Hawley, 2007). A better understanding
of decision needs could impact clinical practice, perhaps optimizing decisional support
and decision quality. This study contributes to the body of knowledge in this area.
Overall, women choosing either surgery were not experiencing severe levels of distress,
depression, anxiety or stress although there were individual variations. Women choosing
mastectomy with contralateral prophylactic mastectomy were more anxious and had more
frequent intrusive thoughts about the diagnosis. They also had less decisional conflict as
compared to women choosing breast conserving surgery. The influence of the surgeon
was very important for women choosing breast conserving surgery. In contrast, family
were the most influential among women choosing mastectomy with contralateral
prophylactic mastectomy. In both groups, intention for surgical choice was matched by
the final decision. There are many factors influencing surgical choice among women
with early stage breast cancer. Previous work has focused on clinical, demographic and
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diagnostic processes influencing the decision. With this study, evidence regarding the
influence of cognitive and affective factors is described.
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Table 4.1
Demographic Characteristics of the Sample (n = 78)

Total
Sample
(n = 78)

Breast
Conserving
Surgery
(n = 47)

Mastectomy with
Contralateral
Prophylactic
Mastectomy
(n = 31)

p

Age (years), mean (± SD)

57 ± 12

62 ± 10

50 ± 11

.000*

Race/Ethnicity
Caucasian
Non-Caucasian

73 (94)
5 (6)

44 (94)
3 (6)

29 (93.5)
2 (6.5)

0.99

52 (66)
25 (33)
1 (1)

30 (64)
16 (34)
1 (2)

22 (71)
9 (29)
0

0.60

23 (30)
38 (49)
16 (20)
1 (1)

15 (32)
24 (51)
7 (15)
1 (2)

8 (26)
14 (45)
9 (29)
0

0.34

Demographic

Marital Status
Married/Partnered
Divorced/Separated/Single/Widow
Missing Data
Education
Elementary/High School
College/University
Graduate School
Missing

Employment
Full- or Part-Time
47 (60)
24 (51)
23 (74)
Other
30 (39)
22 (47)
8 (26)
Missing
1 (1)
1 (2)
0
.05*
Income
< 40,000
16 (21)
10 (21)
6 (19)
40,001 to 80, 000
23 (30)
14 (30)
9 (29)
>80,000
37 (47)
21 (45)
16 (52)
Missing
2 (3)
2 (4)
0
.91
Insurance
Medicaid
4 (5)
4 (9)
0
Any Commercial Insurance
51 (65)
25 (53)
26 (84)
a
Medicare /Medicare + Supplement
22 (28)
17 (36)
5 (16)
Missing
1 (1)
1 (2)
0
Data presented as mean ± SD or frequency (%)
Age compared by independent t-test, Race/Ethnicity compared with Fisher’s Exact test, all
other variables compared with Chi-square tests
*significant p ≤ .05
a
statistical comparison of groups not completed
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Table 4.2
Comparison of Diagnostic Factors between Breast Conserving Surgery and Mastectomy
with Contralateral Prophylactic Mastectomy (n = 78)
Mastectomy
with
Contralateral
Breast
Total
Conserving
Prophylactic
Mastectomy
Sample
Surgery
Diagnostic Factors

(n = 78)

(n = 47)

(n = 31)

p

Breast Magnetic Resonance
Imaging (MRI) prior to surgery
Yes
No

39 (50)
39 (50)

28 (60)
19 (40)

11 (35.5)
21 (65.5)

.037*

Post MRI Biopsy
Yes
No

17 (22)
61 (78)

13 (28)
34 (72)

4 (13)
27(87)

.122

Genetic Counseling
Yes
No

33(42)
45 (58)

13 (28)
34 (72)

20 (64.5)
11 (35.5)

.002*

Genetic Testing Results
Positive
Negative
None

3 (4)
30 (39)
45 (58)

0
13 (28)
34 (72)

3 (10)
17 (55)
11 (35)

.261

Family History in First Degree
Relative
Yes
No

20 (26)
58 (74)

10 (21)
37 (79)

10 (32)
21 (68)

.277

High-Risk (Gail risk ≥ 20%)
8 (10)
3 (6)
5 (16)
Yes
No
70 (90)
44 (94)
26 (84)
.254
Data presented as frequency (%)
Breast MRI prior to surgery, post MRI biopsy, genetic counseling, family history in first
degree relative compared with Chi-square tests
Genetic testing results and high-risk status compared with Fisher’s Exact test
*significant p ≤ .05

71

Table 4.3
Clinical Characteristics of the Sample (n = 78)

Total
Sample

Breast
Conserving
Surgery

Mastectomy
with
Contralateral
Prophylactic
Mastectomy

(n = 78)

(n = 47)

(n = 31)

p

1.5 ± 1.24

1.1 ± 0.67

2.2 ± 1.5

.000*

Tumor Histology
Ductal (In Situ or Invasive)
Lobular (In Situ or Invasive)

71 (91)
7 (9)

41 (87)
6 (13)

30 (97)
1 (3)

.233

Lymph Node Status
Positive
Negative
Not Applicable

8 (10)
58 (74)
12 (15)

2 (4)
33 (70)
12 (26)

6 (19)
25 (81)
0

.134

Estrogen Receptor
Positive
Negative

74 (95)
4 (5)

45 (96)
2 (4)

29 (94)
2 (7)

1.0

Progesterone Receptor
Positive
Negative

75 (96)
4 (5)

45 (96)
2 (4)

29 (94)
1 (3)

1.0

Clinical Characteristics
Tumor Size (cms.),
mean (± SD)

HER2-neu Receptor
Positive
6 (8)
3 (6)
3 (10)
Negative
56 (72)
32 (68)
24 (77)
Not Applicable
16 (21)
12 (26)
26 (81)
1.0
Data presented as frequency (%)
Tumor size compared by independent t-test
Histology, lymph node status, estrogen receptor status, progesterone receptor status and
HER2-neu compared with Fisher’s Exact test
*significant p ≤ .05
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Table 4.4
Properties of Study Scales and Subscales: Depression Anxiety Stress Scale (DASS),
Impact of Events Scale (IES), Decisional Conflict Scale (DCS)
Range
n
M
SD
α
Potential
Actual
Scale/Subscale
DASS
DASS
Depression
Subscale
DASS Anxiety
Subscale
DASS Stress
Subscale

IES
IES Intrusion
Subscale
IES Avoidance
Subscale

DCS
DCS Informed
Subscale
DCS Values
Clarity Subscale
DCS Support
Subscale
DCS Uncertainty
Subscale
DCS Effective
Decision
Subscale

75

20.10

18.09

.96

0 - 126

0 - 75

76

6.38

8.24

.95

0 - 42

0 - 40

78

5.44

6.26

.86

0 - 42

0 - 27

77

9.39

7.32

.91

0 - 42

0 - 25

77

28.20

18.54

.93

0-75

0 - 67

77

13.52

9.49

.89

0-35

0-35

78

14.59

10.17

.87

0-40

0-36

78

9.10

12.62

.95

0-100

0-73.44

78

7.16

12.72

.89

0-100

0-66.67

78

10.04

16.14

.93

0-100

0-75

78

5.56

12.06

.92

0-100

0-75

78

14.85

17.29

.67

0-100

0-75

78

8.17

13.60

.92

0-100

0-75
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Table 4.5
Distribution of Depression, Anxiety, and Stress Scores by Level of Symptom Severity (n =
78)
Depression

Anxiety

Stress

Level*

Range

Frequency
(Percent)

Range

Frequency
(Percent)

Range

Frequency
(Percent)

Normal

0–9

62 (80)

0–7

56 (72)

0 – 14

58 (74)

Mild

10 – 13

2 (3)

8–9

6 (8)

15 – 18

6 (8)

Moderate

14 – 20

6 (8)

10 – 14

7 (9)

19 – 25

13 (17)

Severe

21 – 27

4 (5)

15 – 19

6 (8)

26 – 33

0

Extremely
Severe

28 – 42

2 (3)

20 – 42

3 (4)

34 – 42

0

* Lovibond and Lovibond (1995)
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Table 4.6
Comparison of Scores: Depression Anxiety Stress Scale (DASS) and Subscales, Impact of
Events Scale (IES) and Subscales and Decisional Conflict Scale (DCS) and Subscales
among Women Choosing Breast Conserving Surgery (BCS) or Mastectomy with
Contralateral Prophylactic Mastectomy (CPM)
Mastectomy
BCS
with CPM
Measure (range of potential scores)
DASS Total (0-126)
DASS Depression Subscale (0-42)
DASS Anxiety Subscale (0-42)
DASS Stress Subscale (0-42)

(n = 47)
18 (SD 17)
6 (SD 9)
4 (SD 5)
8 (SD 7)

(n = 31)
24 (SD 19)
7 (SD 9)
7 (SD 8)
11 (SD 8)

p
.587
.592
.004*
.345

IES Total (0-75)
IES Intrusion Subscale (0-35)
IES Avoidance Subscale (0-40)

25 (SD 18)
11 (SD 9)
14 (SD 10)

33 (SD 9)
17 (SD 10)
16 (SD 11)

.503
.006*
.395

DCS Total (0-100)
DCS Informed Subscale (0-100)
DCS Values Clarity Subscale (0-100)
DCS Support (0-100)
DCS Uncertainty (0-100)
DCS Effective Decision (0-100)

10 (SD 15)
8 (SD 14)
7 (SD 12)
7 (SD 14)
13 (SD 19)
10 (SD 16)

8 (SD 8)
5 (SD 8)
4 (SD 8)
4 (SD 8)
17 (SD 14)
6 (SD 9)

.021*
.183
.021*
.053*
.199
.013*

Mean (Standard Deviation)
Independent sample t-test
*significant p ≤ .05
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Table 4.7
Breast Surgery Beliefs and Expectation Scale (n = 77)
Not At All
Important

Somewhat
Important

Important

Very
Important

14 (18)

37 (48)

17 (22)

9 (12)

0

2 (3)

12 (16)

63 (82)

Avoid Radiation

24 (31)

19 (25)

18 (23)

16 (21)

Minimize the length of treatment*

11 (14)

22 (29)

14 (18)

29 (38)

Remove breast for peace of mind

25 (33)

14 (18)

12 (16)

26 (34)

Avoid the need for future
mammograms/breast screening

38 (49)

9 (12)

13 (17)

17 (22)

Do as little surgery as possible

17 (22)

28 (36)

13 (17)

19 (25)

2 (3)

5 (7)

2 (3)

68 (88)

36 (47)

12 (16)

8 (10)

21 (27)

Keep my breast
Minimize the chance of breast
cancer coming back

Minimize the chance of dying of
breast cancer
Have the option to improve my
breasts through reconstruction
Values given as frequency (%)
*missing data = 1
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Table 4.8
Breast Surgery Belief and Expectation Scale Factor Analysis with Varimax Rotation (n =
77)

1

Factors
2

3

BSBE5
Remove breast for peace of mind

.803

.354

-.194

BSBE3
Avoid Radiation

.797

BSBE6
Avoid the need for future mammograms/breast screening

.706

Item

BSBE9
Have the option to improve my breasts through
reconstruction

.266

.511

.275

BSBE2
Minimize the chance of breast cancer coming back

.157

.871

BSBE8
Minimize the chance of dying of breast cancer

.125

.848

BSBE7
Do as little surgery as possible

.192

BSBE1
Keep my breast

-.182

BSBE4
Minimize the length of treatment

.480

77

.105

.806

.101

.747

.537

Table 4.9
Most Influential Information Source of Women Choosing BCS or Mastectomy with CPM
Mastectomy
Total Sample
BCS
with CPM
Most Influential
Information Source
(n = 78)
(n = 47)
(n = 31)
p
Physician
Yes
No
Missing

30 (39)
32 (41)
16 (21)

Spouse/Family
Yes
16 (21)
46 (59)
No
Missing
16 (21)
Data presented as frequency (%)
Comparison by chi-square
*significant p ≤ .05

78

25 (53)
14 (30)
8 (17)

5 (16)
18 (58)
8 (26)

.001*

6 (13)
33 (70)
8 (17)

10 (32)
13 (42)
8 (74)

.015*

Figure 4.1
Sources of Information Identified by Women with Early Stage Breast Cancer Making Surgical Decisions (reported in %, n =
78)
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Figure 4.2
Sources of Information Identified by Women Choosing Mastectomy with Contralateral Prophylactic Mastectomy (CPM) and
Breast Conserving Surgery (BCS) (reported in %, n = 78)
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Women Choosing BCS

CHAPTER FIVE:
Conclusion
The essential basis of shared decision-making is a choice among options. The
options are neither right nor wrong, they are different. Such is the case in clinical practice
with early stage, unilateral breast cancer patients who are making choices among surgery
options. The choices are quite different and are optimally discussed in a shared decisionmaking process between patient and healthcare provider. The goal is a quality decision,
based on personal values and on the best evidence (Ottawa Hospital Research Institute,
2015). In an effort to study the decision making process among women with early stage
breast cancer, this dissertation was undertaken.
Chapter Two of this dissertation is a psychometric evaluation of an anxiety
measure. The Depression Anxiety Stress Scale (DASS), a valid and reliable measure in
various settings, had not been tested with women recalled for false-positive
mammograms. Women in the original study completed questionnaires including the
DASS. In this secondary data analysis, the DASS Anxiety subscale was evaluated in a
subset of 2672 women from the original study. Analysis supported the reliability and
validity of the DASS anxiety subscale with women recalled for false-positive
mammograms.
Anxiety has been reported in women recalled for false-positive mammograms and
in women who are diagnosed with breast cancer (Nelson et al., 2016; Pedersen et al.,
2010). In the breast cancer setting, levels of anxiety have been found to both be
correlated and to not be correlated with surgery type (i.e. breast conserving surgery or
mastectomy) when measured post-operatively (Lim, Devi, & Ang, 2011). There is some
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evidence of coincident anxiety during the decision-making process and elevated levels of
anxiety in the preoperative time period have been consistently described in studies of
women diagnosed with breast cancer (Epping-Jordan et al., 1999; Goel et al., 2001;
Pedersen et al., 2010; Rakovitch et al., 2003).
Chapter Three is a critical review of decisional conflict scales. This review was
undertaken to evaluate decisional conflict scales for use during breast cancer surgical
decision making. The background of scale development and psychometric properties of
decision conflict scales were reported in this chapter. The Decisional Conflict Scale
(DCS) has demonstrated reliability and validity overall but some variation in factor
structure has been reported. The DCS is widely used in research about medical decisionmaking. The analysis from this chapter provided important information for the study
described in Chapter Four.
Chapter Four completes the dissertation with the report of a prospective,
exploratory, cross-sectional, mixed-methods study. The study was designed to generate
new knowledge about factors influencing preference for surgical choice among women
with early stage breast cancer. There has been a lack of prospective research on this
topic. Most of the research conducted to date has been retrospective reviews of large
cancer database information. Some retrospective surveys and interviews with patients
have also been conducted. Prospective studies are needed to describe beliefs,
expectations and emotions which may influence decisions as decision-making takes
place.
In the study described in Chapter Four, factors were compared between subgroups
of women choosing breast conserving surgery (n = 47) and mastectomy with contralateral
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prophylactic mastectomy (n = 31). There was significant difference between the groups
regarding: age, employment, tumor size, completion of preoperative breast magnetic
resonance imaging and genetic counseling. Women choosing mastectomy with CPM
were younger, had larger tumors, and completed genetic counseling prior to surgery
which is consistent with previous reports. Results from this study contradict previous
work in which preoperative MRI has been predictive of bilateral mastectomy. In this
study, women who completed preoperative breast MRI were more likely to choose breast
conserving surgery. Women who worked part- or full-time were more likely to choose
bilateral mastectomy which is a new finding.
Anxiety and breast-cancer specific distress were significantly higher among
women choosing mastectomy with contralateral mastectomy. Decisional conflict was
higher among women choosing breast conserving surgery. The significant differences
between the groups for both anxiety and decisional conflict are new findings. A new
scale, the Breast Surgery Beliefs and Expectations Scale was developed for use in this
study to examine differences between the two groups. Factor analysis was completed and
the resulting three factors were analyzed by subgroup. Significant differences between
the two groups for all three factors were found. Information sources were similar between
the groups but the surgeon was the most influential information source to women
choosing breast conserving surgery and family was the most influential source for those
choosing bilateral mastectomy. This study provides evidence regarding the influence of
factors such as anxiety, intrusive impact, surgery beliefs and expectations, and
information sources in the decision-making process.
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Appendix
Study Packet

#___________

Factors Influencing Preference for Surgical Choice among Women with
Early Stage Breast Cancer
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Demographic Questionnaire

How old are you? ________ years

Instructions: To each item, please circle the response that best describes you
1.Race

4. Marital Status

1. Caucasian (White)

1. Married/Partnered

2. African-American

2. Divorced/Separated/Single/Widowed

3. Hispanic
4. Asian
5. American-Indian
6. Alaskan-Indian
7. Other _______________
2.Education: Circle the highest level of
education completed

5.Employment
1. Employed Full or Part Time

1. Elementary

2. Other

2. High school
3. College/University
4. Graduate School
3.Household Income

6.Insurance

1. Less than $20,000

1. No Insurance/Self Pay

2. $20,001 - $40,000

2. Medicaid

3. $40,001 - $80,000

3. Any commercial insurance (Anthem, Blue

4. More than $80,001

Grass Family Health, United, etc)
4. Medicare with or without a supplement
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Instructions: To each item, please fill in the blanks or circle the response that best
describes you
Do you have a personal history of a genetic mutation that increases the risk of
breast cancer (i.e. BRCA1 or BRCA2)
1) Yes
2) No
3) I don’t know
Has anyone ever told you that your lifetime risk of contracting Breast Cancer was
higher than an average woman of your age?
1) Yes
2) No
3) I don’t know
If yes, please write in your percentage of lifetime risk for developing Breast Cancer if
you know it _____________%
At what age did you experience menarche (first period)?_____________________
At what age was your first live birth?______________________________________
Prior to any biopsies for this breast cancer diagnosis, how many breast biopsies
have you had?
1) 0
2) 1
3) >1
Have any of those biopsies prior to this diagnosis shown any of the following?
Please circle any and all of previous biopsy findings
1) ADH (Atypical Ductal Hyperplasia)
2) ALH (Atypical Lobular Hyperplasia)
3) LCIS (Lobular Carcinoma in Situ)
4) DCIS (Ductal Carcinoma in Situ)
5) Not Applicable/No biopsies prior to this diagnosis
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Family History of Breast Cancer in First Degree Relatives
Please circle “Yes” or “No” indicating any of your relatives who have been
diagnosed with Breast Cancer
Relative

Diagnosed with Breast Cancer

Parent (either mother or father)

Yes

No

Any one sister

Yes

No

More than one sister

Yes

No

Any one daughter

Yes

No

More than one daughter

Yes

No
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DASS
Please read each statement and circle a number 0, 1, 2 or 3 which indicates how much the statement
applied to you over the past week. There are no right or wrong answers. Do not spend too much
time on any statement.
The rating scale is as follows:
0 Did not apply to me at all
1 Applied to me to some degree, or some of the time
2 Applied to me to a considerable degree, or a good part of time
3 Applied to me very much, or most of the time
1

I found myself getting upset by quite trivial things

0

1

2

3

2

I was aware of dryness of my mouth

0

1

2

3

3

I couldn't seem to experience any positive feeling at all

0

1

2

3

4

I experienced breathing difficulty (eg, excessively rapid breathing,
breathlessness in the absence of physical exertion)

0

1

2

3

5

I just couldn't seem to get going

0

1

2

3

6

I tended to over-react to situations

0

1

2

3

7

I had a feeling of shakiness (eg, legs going to give way)

0

1

2

3

8

I found it difficult to relax

0

1

2

3

9

I found myself in situations that made me so anxious I was most
relieved when they ended

0

1

2

3

10

I felt that I had nothing to look forward to

0

1

2

3

11

I found myself getting upset rather easily

0

1

2

3

12

I felt that I was using a lot of nervous energy

0

1

2

3

13

I felt sad and depressed

0

1

2

3

14

I found myself getting impatient when I was delayed in any way
(eg, elevators, traffic lights, being kept waiting)

0

1

2

3

15

I had a feeling of faintness

0

1

2

3

16

I felt that I had lost interest in just about everything

0

1

2

3

17

I felt I wasn't worth much as a person

0

1

2

3

18

I felt that I was rather touchy

0

1

2

3

19

I perspired noticeably (eg, hands sweaty) in the absence of high
temperatures or physical exertion

0

1

2

3

20

I felt scared without any good reason

0

1

2

3

21

I felt that life wasn't worthwhile

0

1

2

3
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Reminder of the rating scale:
0 Did not apply to me at all
1 Applied to me to some degree, or some of the time
2 Applied to me to a considerable degree, or a good part of time
3 Applied to me very much, or most of the time
22

I found it hard to wind down

0

1

2

3

23

I had difficulty in swallowing

0

1

2

3

24

I couldn't seem to get any enjoyment out of the things I did

0

1

2

3

25

I was aware of the action of my heart in the absence of physical
exertion (eg, sense of heart rate increase, heart missing a beat)

0

1

2

3

26

I felt down-hearted and blue

0

1

2

3

27

I found that I was very irritable

0

1

2

3

28

I felt I was close to panic

0

1

2

3

29

I found it hard to calm down after something upset me

0

1

2

3

30

I feared that I would be "thrown" by some trivial but
unfamiliar task

0

1

2

3

31

I was unable to become enthusiastic about anything

0

1

2

3

32

I found it difficult to tolerate interruptions to what I was doing

0

1

2

3

33

I was in a state of nervous tension

0

1

2

3

34

I felt I was pretty worthless

0

1

2

3

35

I was intolerant of anything that kept me from getting on with
what I was doing

0

1

2

3

36

I felt terrified

0

1

2

3

37

I could see nothing in the future to be hopeful about

0

1

2

3

38

I felt that life was meaningless

0

1

2

3

39

I found myself getting agitated

0

1

2

3

40

I was worried about situations in which I might panic and make
a fool of myself

0

1

2

3

41

I experienced trembling (eg, in the hands)

0

1

2

3

42

I found it difficult to work up the initiative to do things

0

1

2

3
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Impact of Event Scale
Instructions: Please read each item, and then indicate how frequently those comments were true
for you during the past 7 days with respect to your experience with breast cancer
0 = Not at all, 1 = Rarely, 3 = Sometimes, 5 = Often
Not at all

Rarely

Sometimes

Often

1. I thought about it when I didn’t mean to

0

1

3

5

2. I avoided letting myself get upset when I
thought about it or was reminded of it

0

1

3

5

3. I tried to remove it from my memory

0

1

3

5

4. I had trouble falling asleep or staying
asleep because of pictures or thoughts
about it that came into my mind

0

1

3

5

5. I had waves of strong feelings about it

0

1

3

5

6. I had dreams about it

0

1

3

5

7. I stayed away from reminders of it

0

1

3

5

8. I felt as if it hadn’t happened or wasn’t real

0

1

3

5

9. I tried not to talk about it

0

1

3

5

10. Pictures about it popped into my mind

0

1

3

5

11. Other things kept making me think about it

0

1

3

5

12. I was aware I still had a lot of feelings
about it but I didn’t deal with them

0

1

3

5

13. I tried not to think about it

0

1

3

5

14. Any reminder brought back feelings about
it

0

1

3

5

15. My feelings about it were kind of numb

0

1

3

5
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Decisional Conflict
A. Which breast surgery option have you chosen? Please check √ one.
Lumpectomy (Breast conserving surgery)
Mastectomy (Removal of one breast only)
Bilateral Mastectomy (Removal of both breasts)
B. Considering the option you prefer, please answer the following questions:
Neither
Strongly Agree
Agree
Disagree
Agree
Nor
Disagree
1. I know which options are available to
me.
2. I know the benefits of each option.
3. I know the risks and side effects of
each option.
4. I am clear about which benefits
matter most to me.
5. I am clear about which risks and side
effects matter most to me.
6. I am clear about which is more
important to me (the benefits or the
risks and side effects).
7. I have enough support from others to
make a choice.
8. I am choosing without pressure from
others.
9. I have enough advice to make a
choice.
10. I am clear about the best choice for
me.
11. I feel sure about what to choose.
12. This decision is easy for me to make.
13. I feel I have made an informed
choice.
14. My decision shows what is important
to me.
15. I expect to stick with my decision.
16. I am satisfied with my decision.
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Strongly
Disagree

Breast Surgery Beliefs and Expectations
Instructions: Circle the number that best indicates the importance of each item as you
were making your decision about surgery.
The rating scale is as follows:
1 = Not at all Important or Not Applicable, 2 = Somewhat Important, 3 = Important, 4 =
Very Important
Not at all
Important

Somewhat
Important

Important

Very
Important

Keep my breast

1

2

3

4

Minimize the chance of breast cancer
coming back

1

2

3

4

Avoid Radiation

1

2

3

4

Minimize the length of treatment

1

2

3

4

Remove breast for peace of mind

1

2

3

4

Avoid the need for future
mammograms/breast screening

1

2

3

4

Do as little surgery as possible

1

2

3

4

Minimize the chance of dying of breast
cancer

1

2

3

4

Have the option to improve my breasts
through reconstruction

1

2

3

4
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Breast Surgery Beliefs and Expectations
Please rank the following 9 factors in order of importance to you as you were making
your surgical choice. 1 = Most Important, 9 = Least Important

__________

Keep my breast

__________

Minimize the chance of breast cancer coming back

__________

Avoid Radiation

__________

Minimize the length of treatment

__________

Remove breast for peace of mind

__________

Avoid the need for future mammograms/breast screening

__________

Do as little surgery as possible

__________

Minimize the chance of dying of breast cancer

__________

Have the option to improve my breasts through reconstruction
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Sources of Information
Please check all of the following which/who served as a source of information to you as
you considered your breast cancer surgical decision
_____Surgeon
_____Gynecologist
_____Primary Care Provider
_____Mammography/Breast Imaging Physician
_____Nurse Navigator
_____Mammography/Breast Imaging Nurse
_____Spouse/Partner
_____Family Member(s)
_____Friend(s)
_____Support Group Members
_____Counselor/Therapist
_____Spiritual/Religious Advisor
_____Internet/Web
_____Informational Brochure/Written Materials
_____Other (please specify)___________________________________________

***Of the choices you marked above, please indicate which/who was the most influential
in your decision. Please circle that response.
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Comment
In your own words, please describe the reason for your surgical choice:

Did your initial intent regarding surgery match your final decision?
Please check yes or no:
Yes

No

Thank you!
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